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Daniel W. Bloodgood: Dissecting the Role of Amygdala Circuits in the Control of Fear 
Extinction and Alcohol Drinking 
(Under the direction of Thomas L. Kash) 
Substance use disorders and mood disorders exhibit high co-morbidity suggesting that 
these conditions may result from changes in common neurocircuits. Here we examine how 
outputs to and from the amygdala are altered in models of excessive alcohol use and Post-
Traumatic Stress Disorder (PTSD). 
In the first set of experiments, we used extinction of Pavlovian conditioned fear to 
understand the type of learning that is impaired in patients with PTSD. Using retrograde 
anatomical tract tracing, we found that distinct sets of neurons in the Prefrontal Cortex (PFC) 
project to the Basolateral Amygdala (BLA) and Nucleus Accumbens (NAc). Next, we 
demonstrated that fear extinction results in output-specific changes in excitability wherein 
PFC projections to the BLA showed increased excitability after extinction training whereas 
the excitability of NAc outputs were unaltered. Finally, we found that the PFC to BLA 
pathway is required for extinction recall in vivo as pathway-specific chemogenetic inhibition 
impaired the recall of a previously acquired extinction memory. These experiments refine our 
understanding of the role of PFC in mediating fear extinction, and suggest that projections to 
the amygdala may be a potential therapeutic target in treating PTSD. 
In the second set of experiments, we examine the contribution of the endogenous 
opioid system in the Central Amygdala (CeA) to regulating excessive alcohol drinking. We 
find that the Kappa Opioid Receptor (KOR) is expressed on largely separate sets of neurons 
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in the CeA than its endogenous ligand Dynorphin (PDYN). Knockout of KOR results in 
reductions in alcohol drinking in male, but not female animals whereas knockout of PDYN 
results in reduced alcohol intake in both sexes. These changes were observed without 
alterations in consummatory or anxiety-like behavior. There were also sex-specific 
alterations in CeA physiology as chronic alcohol decreased the excitability decreased the 
excitability of PDYN neurons in female, but not male animals. These findings highlight the 
potential utility of KOR antagonists in treating Alcohol Use Disorders and demonstrate the 
need to systematically investigate sex differences in the endogenous opioid system. 
Taken together these experiments support using genetic and anatomical specificity to 
understand the role of brain region and cell type in this behavior. These approaches will 
ultimately lead to a more thorough understanding of the alterations in neural circuits that 
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CHAPTER 1: INTRODUCTION 
Psychiatric disorders are highly prevalent in the population, and it is estimated that 
approximately one out five Americans are living with a mental illness (SAMHSA, 2017). 
While mortality from virtually all other types of diseases has declined, the mortality rates 
from psychiatric conditions has remained virtually unchanged (Kessler et al., 2005). Part of 
the reason for this failure is because of the lack of understanding of the etiology of 
psychiatric disorders (Insel et al., 2010). For example, the major classes of drugs used to treat 
psychiatric disorders have largely been reverse engineered based on drugs discovered by 
clinical observation in the 1950s and1960s (Nestler & Hyman, 2010). By contrast, there have 
been over 100 hundred New Molecular Entities (NMEs) approved by the FDA for high blood 
pressure within the same period (Kinch, Haynesworth, Kinch, & Hoyer, 2014). 
Correspondingly, deaths from heart disease declined by over 70% within the same period 
(Cuthbert & Insel, 2013). 
 Another challenge facing mental health treatment is the high degree of comorbidity 
between conditions (Chambers, Krystal, & Self, 2001; Mineka, Watson, & Clark, 1998). 
Indeed, it has recently been suggested that in psychiatry “comorbidity is the norm and not the 
exception” (Gordon, Bellgowan, Lawhorn, & Scheinert, 2019). Given the high rate of co-
occurrence between mood disorders and substance abuse disorders (Regier et al., 1990; Ross 
& Peselow, 2012), this presents an argument for studying these conditions in tandem as both 
classes of disorders are likely due alterations in the same underlying neural circuits. For 
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example, the endogenous stress and reward systems are likely candidates that undergo 
maladaptive changes in both sets of conditions. Individuals who score highly on measures of 
sensation-seeking are at higher risk to abuse drugs (Zuckerman, 1979), and individuals with 
high stress susceptibility are subsequently more susceptible to PTSD after a traumatic event 
(Broekman, Olff, & Boer, 2007) and are more likely to consume excessive amounts of 
alcohol (Pohorecky, 1991).  Not surprisingly then, genetic association studies have 
implicated polymorphisms in the endogenous opioid and stress response systems as 
conveying elevated risk for mood and substance use disorders (Blomeyer et al., 2008; Taqi et 
al., 2011; Treutlein et al., 2006; Xuei et al., 2006). Taken together, these findings provide a 
strong rationale for understanding the normal function of opioid and stress circuits in order to 
better understand how they may be altered in psychiatric conditions. 
Historical Perspectives on Endogenous Stress & Reward Systems 
Morphine in the form opium was consumed for many centuries for its analgesic and 
mind-altering properties (Attumonelli, 1802). However, it was not until the 1940s and 1950s, 
and the synthesis of different opioid derivatives, that opioid receptor pharmacology began to 
be investigated more rigorously (Hart & McCawley, 1944; Wikler, Fraser, & Isbell, 1953). 
Pioneering experiments by William R. Martin showed that morphine and nalorphine could 
produce dependence syndromes with distinct physiological changes (Martin & Eades, 1961, 
1964). This led to the hypothesis that there may be two distinct opioid receptors, one of 
which bound morphine and another that bound nalorphine (Martin, 1967). Further 
experiments implicated though there was likely a three-receptor model, which they termed μ, 
κ, and σ for the types of prototypical agonists which produced the effects (Gilbert & Martin, 
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1976; Martin, Eades, Thompson, Huppler, & Gilbert, 1976). It was during this time that Pert 
& Snyder (1973) demonstrated saturable, stereospecific binding of an opioid agonist, 
confirming that the effects of morphine are likely mediated through an opioid specific 
receptor in the brain.  
With the functional properties of various opioid agonists and antagonists elucidated, 
the question arose as to whether the brain possessed endogenous ligands for these receptors. 
Shortly thereafter, β-endorphin and two isoforms of enkephalin were biochemically isolated 
(Hughes et al., 1975; Teschemacher, Opheim, Cox, & Goldstein, 1975).  Curiously though, 
the enkephalins showed distinct pharmacological properties from β-endorphin and it was 
speculated that the enkephalins were agonists at a different receptor.  This was subsequently 
termed δ owing to its abundance in mouse van deferens tissue (Lord, Waterfield, Hughes, & 
Kosterlitz, 1977). It was then later shown that dynorphin bound with high specificity to the κ 
receptor (Chavkin, James, & Goldstein, 1982) whereas the σ receptor was in fact non-opioid 
in nature (Mansour, Khachaturian, Lewis, Akil, & Watson, 1988). 
During this time research also began to explore the diverging roles of different 
receptor type activation and to examine how these may contribute to psychiatric disorders. 
For instance it was shown that μ agonists resulted in appetitive responses as measure through 
conditioned place preference, whereas κ agonists produced a conditioned place aversion 
(Mucha & Herz, 1985; Shippenberg & Herz, 1987). This, along with the finding that κ 
receptor activation led to dysphoria in human subjects (Pfeiffer, Brantl, Herz, & Emrich, 
1986), cemented the idea that κ receptors are a type of opioid receptor that produces 
analgesia without euphoria. Furthermore, it was later found that dynorphin was upregulated 
in the brains of human addicts (Hurd & Herkenham, 1993) and that KOR agonism can block 
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cocaine locomotor sensitization (Heidbreder, Goldberg, & Shippenberg, 1993) laying the 
groundwork for KORs as a potential treatment for substance use disorders. 
In this same timeframe, progress was also being made in understanding the 
endogenous stress system. The discovery of the structure of corticotropin releasing factor 
(CRF) (Vale, Spiess, Rivier, & Rivier, 1981) led to the development of many new analogue 
compounds in order to probe receptor function. However the abundant presence of CRF 
outside of the hypothalamus suggested that it might also act as a peptide transmitter in the 
brain (Swanson, Sawchenko, Rivier, & Vale, 1983). It was subsequently found that there are 
increased levels of CRF in the cerebrospinal fluid of post-mortem samples from suicide 
victims (Arató, Bánki, Bissette, & Nemeroff, 1989). Subsequent work in model organisms 
found that acute stress upregulates CRF in the amygdala (Pich et al., 1995). Moreover, CRF 
signaling activation can promote acoustic startle (Lee, Schulkin, & Davis, 1994) and prime 
drug reinstatement (Shaham et al., 1997).  
This work led to an interest in the endogenous stress system as an area of possible 
therapeutic intervention. However, compounds targeting CRFR1 have either shown adverse 
side effects or proven ineffective in clinical trials (Spierling & Zorrilla, 2017). Evidence 
suggests though that there may be interaction between the endogenous stress and opioid 
system with PDYN/KOR signaling mediating the dysphoric component of stress (Land et al., 
2008). Indeed it was shown that in the basolateral amygdala, activation of KOR contributed 
to CRF-induced increases in anxiety-like behavior (Bruchas, Land, Lemos, & Chavkin, 
2009). Given that KOR is still seen as a viable therapeutic target (Carlezon & Krystal, 2016; 
Chavkin & Koob, 2016), this research suggests that KOR pharmaceutics may be useful for 
treating affective disorders as well. 
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Recent years have produced a host of new tools to manipulate genetically defined cell 
types (Armbruster, Li, Pausch, Herlitze, & Roth, 2007; Boyden, Zhang, Bamberg, Nagel, & 
Deisseroth, 2005). While transgenic mouse lines provide powerful tools for manipulating 
circuit function, there are inherently many challenges with modeling psychiatric disorders in 
rodent models (Nestler & Hyman, 2010). Recent approaches, outlined by the Research 
Domain Criteria (RDoC), have de-emphasized attempts to model specific clinical diagnoses 
as these may represent an arbitrary cluster of symptoms rather than a true unique condition 
(Cuthbert & Insel, 2013). Rather, they suggest, effort should be focused on understanding 
specific symptoms that may be altered in an aberrant state. For example, the 
withdrawal/negative affect stage of the addiction cycle (Koob & Volkow, 2009) has clear 
parallels with the “Negative Valence Domain” of RDoC. Thus, studying the brain’s 
emotional circuitry will provide important insights for understanding the mood alterations 
that underlie substance use disorders. 
Conditioned Fear As A Model of Defensive Learning 
One aspect of the negative valence domain is the response to acute threats or fear. 
Pavlovian Conditioned Fear has emerged as a valuable assay for examining the neural 
circuits involved in mediating the response to aversive stimuli (Hitchcock & Davis, 1986; 
LeDoux, Iwata, Cicchetti, & Reis, 1988). In this paradigm, a Neutral Stimulus (NS) such as 
an auditory tone is paired with an aversive Unconditioned Stimulus (US) such as a foot 
shock. The normal adaptive response of laboratory mice to the US is to engage in freezing 
behavior which allows the animal to avoid detection by a predator. Through repeated pairing 
of the NS and US, animals will begin to show a conditioned response to the NS at which 
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point it becomes a conditioned stimulus (CS+). Thus, the conditioned response (CR), 
freezing behavior, can be quantified as an index of fear learning. 
Additionally, multiple variations of this paradigm exist wherein animals can be tested 
in recall phase in different environments to assess the effects of both the cue and the 
conditioning context. Manipulations may be performed prior, during, or after acquisition of 
this fear memory, as well as before and during recall, that is, presentation of the CS without 
the US. These interventions can be used separate the role of neural circuits on acquisition, 
encoding, retrieval or expression of the fear memory. In some versions of fear conditioning, a 
second auditory tone that is distinct from the CS+ can also be presented during acquisition 
and is delivered without a foot shock. This serves as a CS that denotes the absence of a US 
(CS-). Manipulations that impair discrimination between the CS+ and CS- thus promote fear 
generalization, which is a trait that is observed in a variety of psychiatric conditions (Grillon 
& Morgan III, 1999; Jovanovic et al., 2010).  
Review of Functional Amygdala Anatomy 
 Studies across multiple species including human subjects have implicated the 
amygdala as an important nucleus for the acquisition and expression of conditioned fear 
(Blanchard & Blanchard, 1972; LaBar, Gatenby, Gore, LeDoux, & Phelps, 1998; 
Weiskrantz, 1956). Because of the robustness and relatively quick time scale of conditioning 
and recall phases, much progress has been made in dissecting the flow of information 
through different amygdala subnuclei. Briefly, information about the CS converges from the 
auditory thalamus on the lateral amygdala (LA) which undergoes potentiation following 
repeated CS-US pairings (McKernan & Shinnick-Gallagher, 1997; Rogan, Stäubli, & 
LeDoux, 1997). The LA then projects to the basolateral amygdala (BLA) which forms 
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reciprocal connections with cortical regions, and the central amygdala (CeA). The CeA then 
projects to the bed nucleus of the stria terminalis (BNST) as well as hindbrain nuclei 
including the periaqueductal gray (PAG), the parabrachial nucleus (PBN), and the nucleus of 
the tract solitarius (NTS) (Ye & Veinante, 2019). The CeA also receives projections from the 
LA and has been shown to involved in the expression of conditioned fear suggesting a 
“lateral to medial” flow of information through the amygdala (Janak & Tye, 2015). It should 
be noted that it has recently been shown that the CeA relays information about the US back 
to the LA (Yu et al., 2017). While this effect appears to be mediated by CeA projections 
outside of the amygdala that then project back to the LA, this suggests that there is recurrent 
processing of information rather than a simple unidirectional flow.  
The CeA can also be broken down into further anatomical subdivisions including the 
central lateral subdivision (CeL) and central medial subdivision (CeM). While it has been 
suggested that neurons in the CeL form predominantly local projections which serve to 
inhibit outputs of the CeM (Ciocchi et al., 2010), this is inconsistent though with anatomical 
data showing labeling in the CeL from a variety of output brain regions (Ye & Veinante, 
2019). Additionally, direct projections from the CeL to the PAG mediate a conditioned 
freezing response (Penzo, Robert, & Li, 2014) providing further evidence that the CeL is an 
output nucleus and not merely a relay structure. While the CeL and CeM vary in their 
expression of different cell types (J. Kim, Zhang, Muralidhar, LeBlanc, & Tonegawa, 2017) 
and undergo different adaptations in response to behavioral paradigms such as chronic 
alcohol exposure (Pleil, Lowery-Gionta, et al., 2015), the present review will focus more 




Role of Genetically Defined Cell Types in the Acquisition of Conditioned Fear 
In vivo electrophysiology recordings have identified subsets of CeA neurons that 
either increase their firing in response to the CS+ (termed “fear on” cells), or show 
suppressed firing to the CS+ (termed “fear off”) (Ciocchi et al., 2010). Notably, “fear on” 
units responded to the CS+ with a shorter latency than “fear off” units, and it was postulated 
that fear on units inhibit fear off units to promote freezing behavior. A major advancement 
was the identification of Somatostain (SST) and Protein Kinase C Delta (PKCD) neurons as 
the fear on and fear off cell types respectively (Haubensak et al., 2010; H. Li et al., 2013). 
This model is supported by the fact that SST and PKCD cell types share minimal overlap (J. 
Kim et al., 2017), have distinct outputs (Ye & Veinante, 2019), and that SST and PKCD cell 
types mutually inhibit one another (Haubensak et al., 2010; Pomrenze et al., 2015). 
Recent work in this area suggests that a refinement of our understanding of these cell 
types necessary. In contrast to previous findings, Yu et al. (2017) demonstrated that 
inhibition of PKCD neurons during fear acquisition led to a decrease conditioned freezing 
rather an increase as observed by Haubensack et al. (2010). However, this is not necessarily 
incompatible with the fear on/off cell type model. Haubensak et al used the Glu-
Cl/Ivermectin system which led to only small and transient increases in freezing behavior. 
This stands in contrast to the more robust optogenetic inhibition performed by Yu et al. that 
resulted in substantial reductions in freezing. It should be noted that the term “fear off” was 
termed because the recorded units showed decreased firing to the CS+. However, this not 
necessarily mean that these units themselves are involved in the suppression of freezing 
behavior, but rather that their activity is decreased by CS+ responsive neurons. 
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Another interpretation of the data is that PKCD neurons promote a type of innate 
freezing that is distinct from the conditioned freezing induced by SST neuron activation. This 
hypothesis is supported by findings from Kim et al. (2017) showing that activation of 
anterior PKCD neurons in the CeC on their own is sufficient to induce freezing behavior in 
the absence of salient behavioral cues. Additional support for this theory comes from the fact 
that there is a high degree of overlap between PKCD and CALCRL cell types (J. Kim et al., 
2017), and that stimulation of CALCRL neurons is also sufficient to promote innate freezing 
(Han, Soleiman, Soden, Zweifel, & Palmiter, 2015). It should be noted however, that Botta et 
al. (2015) did not find any effects of PKCD neuron activation on innate freezing. This 
difference may be due to the fact that Botta et al. used continuous optical stimulation whereas 
the other studies used relatively high frequencies of stimulation of 30 Hz (Yu et al., 2017) 
and 40 Hz (Han et al., 2015). Thus, these neurons may have graded response based on the 
stimulation frequency or stimulation waveform used. 
More intriguing yet, is the finding that CALCRL stimulation alone is sufficient to 
mimic the US signal (Han et al., 2015). This is corroborated by the work of Yu et al. (2017), 
where in vivo imaging of PKCD neurons demonstrated that they respond to the US and not 
the CS. Importantly, they also found that inhibition of PKCD neurons during the US alone is 
sufficient to impair learning. These findings then shed new light on the results of (Botta et 
al., 2015) which show that activation of PKCD neurons promotes fear generalization. 
Logically then, PKCD neuron activation would promote generalization, as stimulation during 
the CS- would provide a US signal to induce a freezing response thus resulting in the lack of 




Genetically Defined Cell Types For Divergent Defensive Responses 
 As demonstrated by the refinement of the idea of “fear off” neurons, further 
refinement of SST neurons solely as a “fear on” population may also be required. All of the 
studies reviewed so far have been conducted in standard operant chambers wherein the 
adaptive response is to engage in freezing behavior. In a novel paradigm, Fadok et al. (2017) 
provide an additional “safe” compartment in which no footshock is delivered. In this assay, 
the authors find that activation of CeA corticotropin releasing factor (CRF) neurons promote 
active avoidance whereas CeA SST neuron activation promotes passive freezing, suggesting 
that the CeA may promote competing defensive strategies. While some groups show minimal 
overlap between these cell types (Sanford et al., 2017), other groups have estimated the 
overlap to be anywhere from 40% (Pomrenze et al., 2015) to as high as 70% (J. Kim et al., 
2017). One question then is how such highly overlapping populations may mediate divergent 
behavioral responses. Fortunately, such questions can now be addressed with novel 
transgenic mouse lines. Specifically, those expressing flp recombinase which in combination 
with cre lines can be used to genetically target two populations in the same animal. With the 
availability of INTRSECT vectors (Fenno et al., 2014) allowing targeting of specific 
populations at the exclusion of others, it would be interesting to examine the distinct role of 
neurons that are positive for SST only, CRF only, and neurons that co-express both.  
Role of Neuropeptide Signaling 
A shortcoming of these studies though is that SST, CRF, and PKCD are used as 
genetic markers, but the roles of these neuropeptides and kinases themselves have been 
overlooked. Because neuropeptide modulators are released on a slow time scale (van den Pol, 
2012), one possibility is that may play a distinct role from the fast-acting neurotransmitters 
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expressed in a population. Indeed the theory that neuropeptides “fine-tune” a behavioral 
response is an attractive idea, yet few studies have demonstrated a role for this in vivo 
partially due to the difficulty of measuring neuropeptide release (Kash et al., 2014).  
This question was recently addressed by Sanford et al. (2017) who demonstrated that 
CRF is involved in the acquisition of cued fear to low intensity (0.3mA) but not high 
intensity (0.5mA) footshocks. In this study, the authors elegantly demonstrate that selective 
knockout of CRF in the CeA impairs the acquisition of low intensity (0.3 or 0.4 mA) but not 
high intensity (0.5mA) cued fear response. They then go on to show that low intensity fear 
conditioning increases AMPA Currents in CRF neurons, and that exogenous CRF can 
increase glutamatergic transmission onto CRFR1 neurons in the CeA. Finally, the authors 
demonstrate that site-specific CRFR1 antagonism in the CeA impairs low intensity freezing 
responses, suggesting that CRF is normally released under low-intensity conditions.  
However, pharmacologic manipulation cannot distinguish between CRFR1 receptors 
present on glutamatergic projections to the CeA (Silberman & Winder, 2013) or CRFR1 
neurons present on CeA neurons themselves (Nie et al., 2009). The authors demonstrate that 
exogenous CRF increases glutamatergic transmission onto CRFR1 neurons and hypothesize 
that CRFR1 neurons mediate the freezing response. However, CRFR1 is expressed broadly 
in the CeA (Herman and Kash Lab unpublished data) and CRFR1 neurons likely overlap 
with both SST and PKCD cell types. Thus, it is unclear how manipulation of the CRFR1 cell 
type on its own would affect freezing. One attractive idea is that CRF, through CRFR1, shifts 
excitation onto the “fear off” (non-CRF or PKCD) cell type to potentiate the US signaling, 
thus increasing freezing at low intensities (Figure 1.2). Indeed, the authors show that CRF 
potentiates glutamatergic transmission from the LA providing a potential source for this 
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excitatory drive. If the source of the CRF was found to be released locally by CeA neurons, 
then this would be a form of heterosynaptic regulation of excitatory transmission, similar to 
what has been shown with BNST neurons (Crowley et al., 2016).  
It also bears noting that when the authors silence all transmission from CRF neurons 
with Tetanus Toxin (TeTx), the effect size is larger than with CRF knockout only. Besides 
the obvious effects on GABAergic transmission, it is tempting to speculate that other 
peptides may also be involved. Histology by the authors shows that CRF is separate from 
both SST and PKCD cell types, however data from Kim et al. (2017) suggests that CRF 
neurons overlap to a high extent with PDYN, SST, and Neurotensin (NTS) cell types.  
Additionally, CeA CRF neurons also have a high degree of co-expression of tachykinin 2 
(Tac2) (J. Kim et al., 2017), and it has recently been shown that CeA Tac2 siRNA 
knockdown can impair cued fear acquisition in socially isolated animals (Zelikowsky et al., 
2018 and personal communication). These findings raise the intriguing possibility that 
peptides may be released in a combinatorial fashion to grade a stimulus response. 
Additionally, they highlight the importance of moving beyond using peptides solely as 
genetic markers and to study the receptor systems through which they signal to mediate a 
behavioral output.  
Role of Genetically Defined Cell Types on Anxiety and Appetitive Behaviors 
Assessing Anxiety Behaviors Across Species 
RDoC also identifies another aspect of the Negative Valence Domain as the response 
to threats that are less predictable in nature. This corresponds to anxiety, or the state of 
heightened arousal in response to a diffuse or unpredictable threat. Like fear, anxiety is 
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evolutionarily adaptive response the promotes the avoidance of dangerous contexts. 
However, anxiety in the absence of a credible threat can become pathological, and highly 
prevalent in the population as anxiety disorders are one of the common types of mood 
disorders (Kessler et al., 2005). Many assays have been developed to model anxiety-like 
behavior in rodents which have been reviewed extensively elsewhere (Calhoon & Tye, 2015; 
Griebel & Holmes, 2013). Broadly, one class of these assays relies on placing mice into an 
apparatus with differently lit compartments and assessing their exploration of the novel 
environment. These assays generate an internal conflict for the animal as mice have an innate 
proclivity to explore novel environments as well as a strong aversion to bright open spaces 
that serves to avoid predation. The two assays referenced here, the Elevated Plus Maze 
(EPM) and Open Field (OF), both rely on this principle. 
Role of Amygdala Circuits in Mediating Anxiety 
Canonically, the CeA was conceptualized to be involved in cued fear whereas the 
BNST was thought to be involved in contextual fear and anxiety (D. L. Walker & Davis, 
1997). However, several recent studies have established a role for the CeA in mediating 
anxiety behavior (Ahrens et al., 2018; Botta et al., 2015; Cai, Haubensak, Anthony, & 
Anderson, 2014; Pomrenze et al., 2019). Notably, as with conditioned fear, there appear to be 
two cell types which may play opposing roles on anxiety. First, it has been shown that 
chemogenetic activation of CRF neurons reduces open arm time in the EPM and center time 
in the OF consistent with an anxiogenic profile (Pomrenze et al., 2019). Likewise, increasing 
glutamatergic transmission onto the SST population, which has high levels of overlap with 
the CRF population, also increases anxiety-like behavior (Ahrens et al., 2018). On the other 
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hand, optogenetic activation of the non-overlapping PKCD population increases open arm 
time and center time, consistent with an anxiolytic profile (Cai et al., 2014).  
The idea that genetically identified populations known to play a role in fear 
conditioning in the CeA could play an analogous role in mediating anxiety-like behavior is a 
very attractive one. This is particularly due to the parallel directionality wherein “Fear On” 
neurons promote anxiety and “Fear Off” neurons reduce anxiety. However there a few 
inconsistencies in this model that must be examined more thoroughly. Botta et al. (2015), in 
direct contrast to the findings of Cai et al. (2014), find that activation of PKCD neurons is 
anxiogenic. As was discussed in the case of conditioned fear, this discrepancy may possibly 
be explained by targeting of slightly different anatomic subregions. Later work by Kim et al. 
(2017) found different effects along the anterior/posterior axis of PKCD neurons. 
Specifically, this showed that optogenetic stimulation of anterior PKCD neurons (In mouse: 
Bregma AP -0.8mm) promotes innate freezing behavior whereas stimulation of posterior 
PKCD neurons (Bregma AP -1.6mm) do not. Notably, the stereotaxic coordinates used by 
Cai et al. (2014) were more posterior (AP -1.4 mm) than those used by Botta et al. (2015) 
(AP -1.2 mm). While this difference is not as large the full anterior/posterior range examined 
by targeted by Kim et al. (2017), it does raise the possibility that the different populations 
neurons may have been manipulated based on virus spread. Indeed, Botta et al. found that 
PKCD stimulation resulted in a significant reduction in distance traveled in the open field 
reminiscent of the findings by Han et al. (2015) who targeted the more anterior division of 
CALCRL neurons.  
The idea that there would be different behavioral responses along the A/P axis is one 
that warrants future investigation. One possibility is that the anterior and posterior 
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populations are enriched for different cell types that have different effects on fear and 
anxiety. There is in fact a clear difference in the amount of overlap between CALCRL and 
PKCD along the anterior/posterior axis of the CeA (Han et al., 2015; J. Kim et al., 2017). 
Another possibility is that functional manipulation of either group may lead to different sets 
of neuropeptides released in vivo. Recent work by Al-Hasani et al (2018) is of particular 
interest as they explored the release of opioid receptor ligands in another limbic brain region. 
The authors found that optogenetic stimulation of PDYN neurons results in differential 
release of dynorphin and leu-enkephalin within the dorsal and ventral parts of the nucleus 
accumbens shell. While these experiments are technically challenging to implement, it makes 
the case that additional attention should be given to the molecular output of optogenetic 
stimulation experiments. Indeed, such effects may explain why opposing behavioral 
responses can be observed even within the same cell type in a given brain region (Al-Hasani 
et al., 2015). 
Role of Genetically Defined Cell Types on Bi-Directional Appetitive Responses 
Given the opposing roles between PKCD/CALCRL and SST/PDYN/CRF/NTS 
neurons in fear and anxiety responses, one logical question is to ask whether they similarly 
correspond to appetitive versus aversive behavioral states of the animal. One logical 
hypothesis would be that activation of “fear on” (anxiogenic) neurons would be aversive 
whereas activation of “fear off” (anxiolytic) neurons would be appetitive. Contrary to this, 
Kim et al. (2017) find that optogenetic activation of SST/PDYN/CRF/NTS neurons (“fear 
on”) support operant responding for self-stimulation. One tempting possibility is that 
activation of distinct outputs populations may mediate different behavioral responses. In 
support of this view, stimulation of CRF projections to the BNST promote anxiety 
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(Pomrenze et al., 2019) and contextual fear (Asok et al., 2018). In contrast, NTS projections 
to the PBN promote real time place preference and optical self-stimulation without affecting 
anxiety (Torruella-Suarez et al., 2018). The fact that neurons which promote fear and anxiety 
should engender an appetitive behavioral response is surprising. However this may be similar 
to findings in the BNST which has found that somatic stimulation the region as a whole has 
opposite effects on anxiety than stimulation of its outputs (S.-Y. Kim et al., 2013). 
Additionally, as Kim et al. found that stimulation of different outputs recapitulates different 
aspects of the anxiety state, this providing additional support for the case that appetitive and 
anxiogenic responses may be mediated by projections to different brain regions.  
Another complimentary possibility is that the valence of projections is not fixed, but 
may undergo adaptations as a consequence of behavioral experience. For example, CRF 
neurons share considerable overlap with NTS neurons (Pomrenze et al., 2015) and thus, 
according to the work from Torruella-Suarez et al. (2018) might also be expected to support 
positive valence. However, find that pairing stimulation of CRF neurons with a neutral 
chamber results in a conditioned place aversion. Notably, they did not find an effect of 
activation of this output on real time place preference (personal communication). This 
suggests either (1) the valence of this projection between the two cell types is opposite or (2) 
the directionality changes as a consequence of the conditioning procedure. Given that 
SST/CRF undergo plasticity as a consequence of fear conditioning (Fadok et al., 2017; H. Li 
et al., 2013), it is possible that CRF activation mimics the behavioral state generated by a 





Role of Neuropeptide Systems on Excessive Alcohol Consumption and Withdrawal 
Alcohol addiction is a chronically relapsing disorder which has been shown to engage 
the extended amygdala during withdrawal (Roberts, Cole, & Koob, 1996).  Indeed GABA 
antagonism in each nucleus of the extended amygdala- the central amygdala, bed nucleus of 
the stria terminalis, and nucleus accumbens shell (Hyytiä & Koob, 1995) all decreased 
operant responding for ethanol, with the CeA having the largest effect among these three. 
Early slice electrophysiology studies found that Chronic Intermittent Ethanol (CIE) resulted 
in increased GABAergic transmission in the CeA (Roberto, Madamba, Stouffer, Parsons, & 
Siggins, 2004), which other groups have since replicated (Gilpin et al., 2011; Herman, 
Contet, & Roberto, 2016). In contrast, Pleil et al., (2015) did not find any effects of CIE on 
the frequency or amplitude of inhibitory transmission, but instead found decreased excitatory 
transmission in ethanol exposed animals.  Moreover, this varied by anatomical subregion 
with decreased frequency of both spontaneous and miniature EPSCs in the CeL, but 
decreased excitability and amplitude of spontaneous EPSC only in the CeM. Taken together, 
these findings highlight the importance of examining differences between anatomical 
subregions and genetically defined cell types. 
Corticotropin Releasing Factor 
One of the neuropeptide systems most rigorously studied in the context of alcohol use 
is Corticotropin Releasing Factor (CRF), previously described here in the context of fear and 
anxiety. In the CNS, activation of CRF neurons in the CeA and BNST are thought to engage 
norepinephrine targets in the brainstem (Curtis, Lechner, Pavcovich, & Valentino, 1997) that 
can promote drug reinstatement and relapse (Shaham et al., 1997). Acute stress increases 
CRF levels in the CeA (Pich et al., 1995), and CRF potentiates the effects of acute ethanol 
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(Nie et al., 2004).  Additionally, CRFR1 antagonism in the CeA can protect against alcohol 
in withdrawal-induced increases in anxiety-like behavior (Breese, Overstreet, Knapp, & 
Navarro, 2005), and escalations in alcohol responding (Funk, Zorrilla, Lee, Rice, & Koob, 
2007). This, in tandem with the finding that CRFR1 antagonism can reverse ethanol 
dependence-induced increases in GABAergic transmission in the CeA (Roberto et al., 2010) 
firmly established the role of CRF signaling in the CeA as an important system regulating the 
response to ethanol. 
With advent of new tools to study neural circuits, studies have begun to examine how 
chronic alcohol may affect transmission between brain regions. Recently, it has been shown 
that withdrawal from chronic alcohol activates an “ensemble” of neurons of which is 
enriched for CRF+ cells (Guglielmo et al., 2016). Additionally, silencing CRF neurons in the 
CeA, as well projections to the BNST, reversed dependence-induced operant responding for 
ethanol and somatic signs of withdrawal (Guglielmo et al., 2019). Given that these findings 
implicate hyperexcitability of CRF neurons as part of the pathology of alcohol abuse, this 
seems to be at odds with the model that chronic alcohol augments inhibitory transmission and 
reduces excitatory transmission. One possibility is that chronic alcohol results in cell-type 
specific neuroadaptations in synaptic transmission where inhibitory drive is increased onto 
CRF-, but not CRF+ neurons. Indeed, this has already been shown in CRFR1+ and CRFR1- 
neurons in the CeA following CIE (Herman et al., 2016). 
There is also then the question about the locus of CRF action itself. As mentioned 
previously, antagonism of CRFR1 cannot distinguish between effects on CRF receptors 
present on CeA neurons versus those on presynaptic terminals arising from other brain 
regions. CRFR1 receptors are present on presynaptic projections from the BLA and LA 
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where they augment glutamate release (Silberman & Winder, 2013) as well as on CeA 
neurons where they potentiate GABA release (Nie et al., 2009). Given that CRFR1 
modulation of glutamatergic transmission from the LA was shown to potentiate subthreshold 
freezing in fear conditioning (Sanford et al., 2017), it will be interesting to investigate how 
this input is modulated by chronic alcohol. 
 In addition, since optogenetic inactivation in both the CeA and downstream BNST 
decrease responding for ethanol, this raises the question of whether CRF release at multiple 
sites is required for high levels of ethanol consumption. Given that CRFR1+ neurons in the 
CeA undergo cell type and output-specific increases in excitability (Herman et al., 2016), this 
suggests that CRF release within the CeA may be important as well. However, the functional 
role of CRFR1 neurons, and how they map on to other genetically defined populations in the 
CeA, has not yet been examined. 
Dynorphin 
Another peptide system extensively studied in the central amygdala is the dynorphin 
(PDYN) and Kappa Opioid Receptor (KOR) system. PDYN and KOR are expressed 
throughout the brain and mediate aversive affective states (Crowley & Kash, 2015) and are 
upregulated following withdrawal from drugs of abuse (Butelman, Yuferov, & Kreek, 2012). 
Systemic KOR antagonism decreases operant responding for ethanol (B. M. Walker & Koob, 
2007), and protects against dependence-induced increases in anxiety (Valdez & Harshberger, 
2012). KOR antagonism in the CeA similarly decreases ethanol self-administration and 
symptoms of withdrawal (Kissler et al., 2014). Additionally, chemogenetic inhibition of CeA 
dynorphin neurons, as well as KOR antagonism, results in significant reductions in binge-like 
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drinking, implicating a role for both PDYN/KOR signaling in the CeA in regulating alcohol 
consumption (Anderson et al., 2018).  
However, given the high degree of overlap between PDYN and CRF expressing 
neurons (J. Kim et al., 2017; Pomrenze et al., 2015) it is important to consider the distinct 
effects that each of peptide may have on CeA circuitry. KOR signals via Gi/o mechanisms to 
reduce GABA release (Gilpin, Roberto, Koob, & Schweitzer, 2014; Kang-Park, Kieffer, 
Roberts, Siggins, & Moore, 2013) whereas CRFR1 signals via Gs mechanisms to increase 
GABA release (Nie et al., 2009). Thus, PDYN and CRF would have opposing effects on the 
post-synaptic neuron. As CRFR1 exhibits a much broader expression pattern in than KOR in 
the CeA (Kash Lab Unpublished Data), the net effect will ultimately be determined by the 
receptor expression profile. There may also be a broader significance of direct interactions 
between PDYN and CRF. For example, it has been shown CRF causes release of PDYN in 
the CeA (Kang-Park et al., 2015). As approximately 50% of PDYN neurons express CRFR1 
(Kash Lab Unpublished Data), this may be a potential feedback mechanism wherein 
enhanced CRF release may also amplify the gain of PDYN release. 
Commonalities Between Fear and Alcohol Induced Plasticity 
The alcohol field has done extensive work to understand the pharmacology of 
compounds that control intake, but the knowledge of the underlying circuitry on which they 
act is much more limited. Fortunately, findings from the fear and anxiety literature can 
provide insights into the way in which ethanol may modulate CeA circuitry to produce 
maladaptive behavior. Given the relatively fast time scale of fear conditioning and recall, this 
paradigm has obvious advantage for examining the reshaping of amygdala circuitry. 
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However, as changes resulting from alcohol drinking typically take weeks to manifest, the 
types of plasticity observed from a history of alcohol use may be different than that of a 
relatively brief event like fear conditioning. 
Modulation of fear and anxiety circuitry has clearly delineated the role of two 
different cell types of PKCD and SST. It should be noted the primary neuropeptides that have 
been examined in the context of alcohol research, CRF, PDYN, and NTS all share a high 
degree of colocalization with SST. This then raises the question of how PKCD neurons act in 
concert with SST neurons to control alcohol intake. Interestingly, PKCD neurons share a 
high degree of overlap with Preproenkephalin (PENK) (J. Kim et al., 2017) which encodes 
the endogenous ligands for mu opioid receptors (MOR) and delta opioid receptors (DOR) 
(Bower, Guest, & Morgan, 1976). Both of these receptors are expressed within the CeA and 
have been shown to have distinct responses to acute alcohol. How these systems interact with 
other receptors in response to chronic alcohol is an area likely to be fruitful for investigation. 
Another unanswered question is whether different outputs play separable roles in the 
alcohol abuse phenotype. In support of this idea, CRF projections to the BNST promote 
alcohol consumption (Guglielmo et al., 2019), but also anxiety-like behavior (Pomrenze et 
al., 2019). By contrast, NTS projections to the PBN promote alcohol consumption and 
reward, but not anxiety-like behavior (Torruella-Suarez et al., 2018). Refining the role of 
neuropeptide signaling in an output-specific manner may provide important insights into past 
findings. For example, CRFR1 antagonism in the CeA reduced binge-like alcohol 
consumption in the Drinking in the Dark (DID) model whereas CRFR2 activation non-
specifically decreased caloric consumption (Lowery-Gionta et al., 2012). It is tempting then 
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to speculate that these two receptors may be markers for different outputs which would 
explain the divergent behavioral response.  
Broadly, the central amygdala, with its diverse role in integrating information about 
internal and external states, is well-positioned to regulate alcohol consumption. Because CeA 
outputs promote anxiety, but also reward and caloric consumption, it appears likely that 
chronic alcohol may drive increased intake by enhancing both of these functions. 
Conclusion and Perspective 
In summary, considerable progress has been made in the last few years in 
understanding the role of the amygdala in regulating conditioned fear and alcohol 
consumption. Moreover, the present review points to the value of converging genetic and 
pharmacological methods. This combination of approaches allows for a unique synthesis of 
ideas and hopefully will lead to more effective therapeutic approaches. For example, crystal 
structures for all three opioid receptors, have been generated in recent years (Granier et al., 
2012; Manglik et al., 2012; Wu et al., 2012). Additionally, structures of these receptors in 
their active state have also been solved (Che et al., 2018; Huang et al., 2015) providing 
important clues as to how these receptors may function in vivo. The ultimate goal of this 
preclinical research is to provide the basis for rational drug design that would incorporate 
information about the different signaling pathways coupled to these receptors. This diversity 
of receptor signaling in vivo could then be exploited therapeutically to produce desired 
activation or inhibition of a specific brain region. 
For example, KORs on GABAergic CeA inputs to the BNST have been shown to 
signal through extracellular signal-regulated kinase (ERK 1/2) (C. Li et al., 2012). By 
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contrast, KORs on glutamatergic BLA inputs to the BNST have been shown to signal 
through p38/MAP Kinase but not ERK or Protein Kinase A (PKA) (Crowley & Kash, 2015). 
Thus, if activation or inhibition was desired, a biased agonist with KOR function could be 
used to shift the balance of these two inputs. This integration of knowledge at level of genes, 
receptors, and circuits will be critical building in working towards a “tissue level” 
understanding of psychiatric disorders (Deisseroth, 2014). With this knowledge, it will then 
be possible to develop precision therapeutics that treat the underlying etiology of the 
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CHAPTER 2: FEAR EXTINCTION REQUIRES INFRALIMBIC PROJECTIONS TO 
THE BASOLATERAL AMYGDALA1 
Introduction 
 Fear extinction, a process by which learned fear responses are reduced through new 
inhibitory learning, has emerged as a translationally valuable assay for studying anxiety and 
trauma-related disorders (Bukalo, Pinard, & Holmes, 2014; Milad & Quirk, 2012; Singewald, 
Schmuckermair, Whittle, Holmes, & Ressler, 2015).  Previous evidence from multiple lines of 
inquiry strongly implicates the medial prefrontal cortex (mPFC) in the mediation of extinction 
(Likhtik & Paz, 2015; Milad & Quirk, 2012; Rozeske, Valerio, Chaudun, & Herry, 2015; 
Tovote, Fadok, & Luthi, 2015), but the precise position of this region within the broader brain 
network underlying extinction remains incompletely understood.  Recent studies in mice have 
shown that neuronal outputs from the ventromedial PFC (vmPFC), containing the infralimbic 
cortex (IL) region, to the basolateral (BLA) (Bukalo et al., 2015a; Cho, Deisseroth, & 
Bolshakov, 2013a; Strobel, Marek, Gooch, Sullivan, & Sah, 2015) and basomedial (BMA) 
(Adhikari et al., 2015), as well as reciprocal connections from BLA to IL (Senn et al., 2014; 
Vogel, Krabbe, Grundemann, Wamsteeker Cusulin, & Luthi, 2016) and projections from BLA 
to NAc (Correia, McGrath, Lee, Graybiel, & Goosens, 2016) are important for extinction. 
 While these data suggest IL-BLA projection neurons represent a critical circuit for 
extinction, they require substantiation using alternative approaches.  Current data also fail to 
adequately address the question of whether the functional role of the IL-BLA circuit is 
redundant to other major IL projection pathways.  For example, it remains unclear whether IL 
1This chapter has previously been published. The original citati n is as follows:  Bloodgood, D. 
W., Sugam, J. A., Holmes, A., & Kash, T. L. (2018). Fear extinction requires infralimbic cortex 
projections to t  basolateral amygdala. Translational psychiatry, 8(1), 60. 
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projections to the nucleus accumbens (NAc) mediate extinction despite reports that functional 
manipulations in the NAc, including dopamine D2 receptor blockade (Holtzman-Assif, 
Laurent, & Westbrook, 2010) and virally-driven activation of the transcription factor cAMP 
response element binding protein (CREB) (Muschamp et al., 2011), can produce significant 
deficits in fear extinction.    
 The goal of the current study was to further examine the contribution of the IL-BLA 
pathway to fear extinction and determine whether IL-NAc projections played a complementary 
or distinct role in extinction.  To this end, we first traced projection neurons from IL and PL to 
the BLA and NAc, in order to evaluate the degree to which the prefrontal efferents to these 
regions overlapped.  We next performed ex vivo electrophysiological recordings to test whether 
fear extinction differentially affected the excitability of IL-BLA, PL-BLA and IL-NAc 
projection neurons.  To then establish causal contributions of the PFC-BLA to extinction, we 
chemogenetically inhibited this pathway and assessed the behavioral consequences. 
Materials and Methods 
Subjects 
 Adult male C57BL/6J mice (The Jackson Laboratories, Bar Harbor, ME, USA), at least 
8 weeks of age, were used for all experiments.  Mice were group-housed in a colony room with 
12:12 h light-dark cycle with lights on at 0700 hr.  Mice had ad libitum access to rodent chow 
and water.  The Institutional Animal Care and Use Committee of the University of North 






 PFC cells projecting to the BLA or NAc were visualized using the retrograde tracer 
Cholera Toxin B (CTB) (Invitrogen, ThermoFisher Scientific, Waltham, MA, USA).  Using 
stereotaxic surgery, 0.3 μl CTB labeled with either Alexa 488 or Alexa 555 (0.5% 
weight/volume, in sterile PBS) was bilaterally delivered into the BLA and NAc at a rate of 0.1 
μl per minute using a 1 μl Hamilton Syringe (Hamilton Company, Reno, NV). The dye 
conjugate (Alexa 488 or Alexa 555) that was injected into each region was counterbalanced 
across mice (for schematic, see Figure 2.1a, upper panel).  The injection coordinates for the 
BLA were 1.3 mm posterior to bregma, 3.25 mm lateral to the midline and 4.95 mm ventral to 
the skull surface.  The coordinates for the NAc were 1.3 mm anterior to bregma, 0.85 mm 
lateral to the midline and 4.75 mm ventral to the skull surface.  The injection needle was left 
in place for at least 5 minutes to ensure diffusion. 
 One week after surgery, mice were deeply anesthetized with an overdose of 
tribromoethanol (250 mg/kg, intraperitoneal) and transcardially perfused with 0.1 M phosphate 
buffered saline (4°C, pH 7.4) followed by 4% paraformaldehyde in PBS.  Brains were post-
fixed for 24 hours in 4% PFA and then cryoprotected in 30% sucrose in PBS.  Tissue sections 
containing the PFC, NAc, and BLA were cut into 45 μm sections using a Vibratome (Leica 
VT1000S, Buffalo Grove, IL, USA) and stored in a 50% glycerol/PBS solution.   
 Correct placements for CTB infusions were verified using a wide-field epifluorescent 
microscope (BX-43, Olympus, Waltham, MA, USA) using a stereotaxic atlas (Franklin & 
Paxinos, 2008).  Quantification of CTB fluorescence and representative images of virus 
expression were collected on a Zeiss 800 Laser Scanning Confocal Microscope (20x objective, 
NA 0.8) (Carl Zeiss, Jena, Germany).  Images were cropped and annotated using Zeiss Zen 2 
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Blue Edition software (for example, see Figure 2.1b). Regions of Interest (ROIs) corresponding 
to Layers 2/3 and Layer 5 of IL and PL were drawn based on areas specified in the Allen Mouse 
Brain Atlas (Allen Institute, Seattle, WA, USA). Quantification of CTB positive cells was 
performed using manual counts with the cell counter plugin in FIJI (Curtis Rueden, LOCI, 
University of Wisconsin-Madison, Madison, WI, USA). A preliminary quantification showed 
that 98.2% of CTB positive cells were also positive for the neuronal marker NeuN, showing 
that CTB almost exclusively labels neuronal cell types. Thus, DAPI was used as a marker of 
nuclei and acquired as a separate channel for all the images used for quantification. The DAPI 
channel has been omitted from the representative image to more clearly show the distribution 
of CTB positive neurons. 
Behavioral procedures 
 Mice underwent fear conditioning and extinction as described previously (Bukalo et 
al., 2015b). Briefly, fear conditioning was performed in Context A: a 30.5 x 24.1 x 21.0 cm 
sound-attenuating chamber with metal walls and grid floor, cleaned with 20% ethanol paired 
with a vanilla scent to provide an olfactory contextual cue.  Following a 120-second baseline 
habituation period, a 30-second 8 kHz 80 dB tone (CS) was presented, co-terminating with a 
2-second 0.6 mA footshock (US) delivered through the grid floor.  There were 5 x CS-US 
pairings, interspersed by a 20-120 second pseudorandomized interval and a 120-second post 
conditioning period after the final pairing.  Freezing behavior was measured as an index of fear 
learning, and was operationally defined as making no movement other than what is necessary 
to breathe. Freezing behavior was quantified using an automated videotracking software 
(Ethovision 9.0, Noldus, Leesburg, VA, USA) with a 1-second minimum threshold for the 
detection of freezing behavior.  
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 The following day, mice underwent extinction acquisition in a novel Context B. The 
chamber used was identical to Context A, but was modified with a clear circular plastic white 
surround and a plastic white insert over the grid floor. In between trials, the chamber was 
cleaned with 70% ethanol without a vanilla scent to provide an olfactory cue that served as 
another distinct attribute of the novel context.  Following a 120-second baseline habituation 
period, there were 50 x CS presentations interspersed by a 5-second inter-trial interval. For 
statistical analysis, the responses were binned across five CS presentations to examine changes 
in freezing behavior across ten cue blocks.  In the chemogenetic experiment, there was an 
additional test day during which mice were returned to Context B the day after extinction 
acquisition to test for extinction retrieval and, following a 120-second baseline habituation 
period, presented with 5 x CS presentations interspersed by a 5-second inter-trial interval. 
Slice electrophysiology  
 IL and PL cells projecting to the BLA or NAc were visually differentiated using 
fluorescent Retrobeads (for schematic, see Figure 2.2a, 2.3a).  Using the same stereotaxic 
coordinates and procedures described above, 0.3 μl Red Retrobeads (Lumafluor Inc, Durham, 
NC, USA) were bilaterally delivered at a rate of 0.1 μl per minute to the BLA or NAc, in 
different groups of mice.  One week after surgery, mice underwent either fear conditioning or 
extinction training, as described above, and then 10 minutes later, were deeply anesthetized 
with isoflurane and decapitated.  An experimentally-naïve group was also sacrificed.  The brain 
was rapidly removed and placed in ice-cold sucrose-artificial cerebrospinal fluid (aCSF) 
containing (in mM) 194 sucrose, 20 NaCl, 4.4 KCl, 2 CaCl2, 1 MgCl2, 1.2 NaH2PO4, 10 glucose 
and 26 NaHCO3.  Three hundred micron acute brain slices were sectioned on a vibratome and 
transferred to a submerged recording chamber (Warner Instruments, Hamden, CT, USA), 
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where they were perfused with heated (30-31 Celsius), oxygenated aCSF at a rate of 2 ml per 
minute and allowed to equilibrate for 30 minutes before recordings. 
 Recording electrodes (3-5MΩ) were pulled from thin-walled borosilicate glass 
capillaries with a Flaming-Brown Micropipette Puller (Sutter Instruments, Novato, CA, USA).  
Recordings were performed only in cells expressing the fluorescent Retrobeads (pyramidal 
neurons of layer 2/3 and 5 of the PFC).  Intrinsic neuronal excitability and current-injected 
firing was measured in current-clamp mode using electrodes filled with an intracellular 
recording solution containing (in mM) 135 K-Gluc, 5 NaCl, 2 MgCl2, 10 HEPES, 0.6 EGTA, 
4 Na2ATP, and 0.4 Na2GTP. During recording, cells with access resistance greater than 30 
M, that had changes in access resistance greater than 10%, or that had action potentials that 
did not surpass zero were also excluded from the analysis. 
 Measurements of excitability were taken 5 minutes following the establishment of the 
whole-cell configuration.  Intrinsic excitability was assessed via multiple measures: 1) resting 
membrane potential (RMP), 2) rheobase, defined as the minimum amount of current required 
to fire an action potential using a current ramp, 3) the action potential threshold, defined as the 
minimum voltage at which the neuron fired an action potential, and 4) the relationship between 
increasing steps of current and the action potentials fired using a voltage-current plot protocol 
(V-I plot).  To control for differences in RMP, current-injection protocols were performed at 
both RMP and -70 mV.  Signals were digitized at 10 kHz and filtered at 3 kHz using a 
Multiclamp 700B amplifier and analyzed using Clampfit 10.3 software (Molecular Devices, 





Chemogenetic pathway-specific inhibition 
 PFC outputs to the BLA were inhibited using DREADDs.  Using the same stereotaxic 
coordinates and procedures described above, 0.3 μl of the retrograde Herpes Simplex Virus 
(HSV) containing Cre recombinase (HSV-hEF1α-mCherry-IRES-cre, MIT Vector Core, 
Cambridge, MA, USA) was bilaterally injected in the BLA.  In addition, 0.3 μl of KOR-
DREADD (AAV8-hSyn-DIO-HA-KORD-P2A-mCitrine, UNC Vector Core, Chapel Hill, NC, 
USA) or control vector (AAV5-eF1α-DIO-ChR2-eYFP, UNC Vector Core) was bilaterally 
injected into the PFC, focusing on the IL (for schematic, see Figure 2.4a). However, as we 
could not confirm this was solely IL, we refer to these experiments as PFC-BLA. The injection 
coordinates were 1.85 mm anterior to bregma, 0.30 mm lateral to the midline and 2.65 mm 
ventral to the skull surface.  Channel Rhodopsin 2 (ChR2) was used as a control as pilot 
experiments showed it resulted in a comparable degree of cell filling as the KOR-DREADD. 
It was selected on the basis that it was another non-endogenous transmembrane protein and 
would be insensitive to the administration of Sal-B. 
 Six weeks following stereotaxic surgery to allow for virus expression, mice underwent 
fear conditioning, extinction acquisition and extinction retrieval, as described above (for 
schematic, see Figure 2.4d).  Immediately before the fear extinction acquisition session, mice 
were subcutaneously injected with 17 mg/kg Salvinorin B (Sal-B) in DMSO at a 1 μl/g body 
weight injection volume using a 250 μl Hamilton Syringe (Hamilton Company, Reno, NV, 
USA). This dose was selected based on the initial characterization of the KOR DREADD 
(Vardy et al., 2015).  Mice were tested for extinction recall the following day, drug-free. 
 To verify virus expression at the completion of testing, mice were anesthetized, 
perfused and brains were processed, as described above.  To visualize expression of HSV-
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mCherry-IRES-Cre in complex with the KOR-DREADD, a double immunohistochemistry 
labeling procedure directed against mCherry (to visualize Cre) and the HA epitope (to visualize 
KOR-DREADD) was performed using procedures previously described (Vardy et al., 2015).  
Briefly, tissue sections were processed 3x in PBS, followed by 30 minutes of permeabilization 
in PBS with 0.3% Triton-X.  Tissue sections were then blocked in 5% normal donkey serum 
and PBS in 0.3% Triton-X for 1 hour, and incubated with 1:500 rabbit anti-HA (cat# 3724S, 
RRID: AB_1549585, Cell Signaling, Danvers, MA, USA) and 1:500 mouse anti-mCherry 
(cat# ab65856, RRID: AB_1141717, Abcam, Cambridge, MA, USA) for 48 hours at 4 °C.   
For control brains, the same procedure was followed but substituting the HA primary antibody 
for an anti-GFP antibody recognizing eYFP (cat# GFP-1020, RRID: AB_10000240, Aves 
Labs, Tigard, OR, USA).  Next, slices were washed 3x for 5 minutes in PBS with 0.3% Triton-
X and incubated with 1:250 Alexa 488 donkey anti-rabbit (Cat# 711-545-152, RRID: 
AB_2313584, Jackson ImmunoResearch Labs, West Grove, PA) and Cy3 donkey anti-mouse 
secondary antibodies (Cat# 715-165-150, RRID: AB_2340813, Jackson ImmunoResearch 
Labs, West Grove, PA) for 24 hours at 4°C.  Tissue sections were then washed 3x for 5 minutes 
in PBS with 0.3% Triton-X, followed by 2 x 5-minute washes with PBS.  Slides were prepared 
with a Vectashield anti-fade mounting medium containing DAPI (Vector Labs, Burlingame, 
CA, USA). 
 Verification of virus injection site and expression was assessed using a wide-field 
epifluorescent microscope (BX-43, Olympus, Waltham, MA, USA) using a mouse stereotaxic 
atlas (Franklin & Paxinos, 2008).  Mice with mis-targeted viral expression were excluded from 
the analysis.  Representative images of virus expression were acquired a Zeiss 800 Laser 
Scanning Confocal Microscope (20x objective, NA 0.8) (Carl Zeiss, Jena, Germany).  Images 
46 
 
were cropped and annotated using Zeiss Zen 2 Blue Edition software (for example images, see 
Figure 2.4b-c). 
Sample size and replication 
 The target number of samples in each group was determined based on numbers reported 
in published studies. No statistical methods were used to predetermine sample size. Sample 
sizes for each in experiment are listed in the figure legends whereby N denotes the number of 
mice used and n denotes the total number of cells or images analyzed. The retrograde 
anatomical tracing experiments were repeated 3 times, each with a new lot of Cholera Toxin 
B (Figure 2.1). The PFC-BLA specific electrophysiology recordings were replicated across 
two cohorts of animals (Figure 2.2). The PFC-NAc recordings and PFC-BLA chemogenetic 
inhibition experiments were not replicated (Figures 2.3 and 2.4). 
Randomization and blinding 
 All surgical and behavioral manipulations performed on each animal were determined 
randomly. All randomization was performed by an experimenter, and no explicit 
randomization algorithm was used. For retrograde anatomical tracer experiments, the CTB dye 
conjugate injected was alternated between animals. For manual counts of CTB+ cells in the 
PFC, the experimenter was blinded to the injection structure (BLA and NAc) during the 
quantification. In electrophysiology experiments, the treatment condition (naïve, conditioning, 
or extinction) was alternated so that animals from the same condition would not be tested on 
consecutive days. For the chemogenetic inhibition experiments, animals were housed in groups 
of 4 or 5 mice per cage. Animals in the same cage were assigned to the same experimental 
condition (DREADD or control).  Conditions were randomized across cages, and the order in 
which the animals were run was alternated between the two groups within the test sessions. 
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The experimenter was not blinded to the treatment condition for behavior and 
electrophysiology experiments. 
Stastical analysis 
 Groups were compared for RMP, rheobase and action potential threshold using a one-
way analysis of variance (ANOVA), followed by Tukey’s post hoc tests.  The relationship 
between current injection step and the number of action potentials fired was analyzed using 2-
way repeated measures ANOVA, followed by Bonferroni post hoc tests.  Groups were 
compared for freezing across CS-US pairing/CS-presentation during fear conditioning and 
extinction acquisition using 2-way repeated measures ANOVA followed by Tukey’s post hoc 
tests.  Freezing during extinction retrieval was compared between groups using Student’s t-
tests with Welch’s correction where appropriate to account for non-sphericity of the data.  Any 
statistical outliers were detected and removed using Grubb’s outlier tests. All p-values reported 
are the result two-tailed hypothesis testing. Data are presented as mean ± standard error (SEM) 
and were analyzed with GraphPad Prism (GraphPad Software, San Diego, CA, USA). 
Results 
Separate IL and PL projections to BLA and NAc 
 We first sought to examine the relative weighting of IL and PL projections to the BLA 
and NAc, and quantify the degree to which these projections were distinct or overlapping.  To 
accomplish this, we injected two different dye conjugates of the retrograde tracer, CTB, into 
the BLA and NAc and quantified the resulting overlap in the PFC (Figure 2.1a,b).  Using this 
approach, we observed a significant proportion of BLA-labeled cells (38.2% of all cells 
counted) and NAc-labeled cells (58.4%), but only a small proportion of cells (3.4%) that were 
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both BLA- and NAc-labeled (Figure 2.1c,d).  These data suggest there are largely non-
overlapped projections from the IL and PL to the two output regions.   Importantly, we found 
that output neurons were located in both layer 2/3 and layer 5 in these regions, and thus our 
slice physiology experiments focused on output, rather than cell layer. 
Extinction increases the excitability of the IL-BLA, not PL-BLA, pathway 
 On the basis of our initial tracing data indicating separate populations of IL projections 
to BLA versus NAc, our next step was to use retrograde tracers to perform electrophysiological 
recordings from cells in a projection-specific manner.  We injected fluorescent red Retrobeads 
(Lumafluor, Durham, NC, USA) into the BLA to test the differential effects of fear 
conditioning and extinction on the excitability of IL and PL output neurons (Figure 2.2a).  
Behaviorally, we confirmed that fear conditioning produced the expected increase in freezing 
across CS-US pairings that did not differ between the conditioned and to be extinguished 
groups (Figure 2.2b).  Also as expected, repeated CS presentations in the extinction group led 
to decreased freezing to the cue during extinction acquisition (Figure 2.2c). 
 Slice physiological recordings revealed that IL-BLA cells were significantly more 
depolarized (more positive resting membrane potential) after fear conditioning, relative to test-
naïve controls (F2, 21=4.23, p<0.01, post hoc test: p<0.05) (Figure 2.2d), and had a lower 
action potential threshold (potential at first-spike), relative to the extinction group (F2,21=4.78, 
p<0.05, post hoc test: p<0.05) (Figure 2.2e).  Following extinction acquisition, IL-BLA cells 
had a significantly lower rheobase, as compared to naïve controls (F2,21=3.66, p<0.05, post 
hoc test: p<0.05) (Figure 2.2f).  Additionally, extinction was associated with a significantly 
higher number of action potentials after current injection compared to both the naïve and 
conditioning only groups (F40,380=6.25, p<0.01) (Figure 2.2g).  These various physiological 
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changes were evident when neurons were held at RMP, but not at -70 mV, with the exception 
of the V-I plot differences, which were evident at both (data not shown).  In contrast to the 
effects of extinction on IL-BLA projections, PL-BLA cells showed no group differences on 
any of the measures taken (Figure 2.2h-k), irrespective of whether recordings were performed 
at RMP or -70 mV.  Together, these data indicate a preferential shift towards increased intrinsic 
excitability in IL-BLA cells following fear extinction, and suggest that this pathway is more 
likely to be activated after mice have underwent extinction. 
Extinction reverse fear-related plasticity in the IL-NAc pathway but does not alter PL-NAc 
 Our next step was to test whether the extinction-related changes in IL projections to the 
BLA were present or absent in IL and PL neurons projecting to the NAc.  In these mice, fear 
conditioning produced an increase in freezing across CS presentations that did not differ 
between groups (Figure 2.3b).  Moreover, extinction training resulted in a decrease in freezing 
to the CS during the extinction conditioning (Figure 2.3c).  However, neither conditioning nor 
extinction produced any significant change in resting membrane potential, action potential 
threshold, or rheobase whether recorded at RMP (Figure 2.3d-f) or at -70 mV (data not shown).  
At -70 mV (but not RMP, data not shown), action potential firing increased with current 
injection magnitude in a manner that was lower in the fear conditioned group, relative to naïve 
controls, but not the extinction group (current x group interaction: F40,19=1.68, p<0.05) 
(Figure 2.3g). When we recorded from PL-NAc cells, no significant group differences were 
found in any measure of intrinsic excitability (Figure 2.3h-k).  Together, these recording results 
show that the fear conditioning leads to a suppression of firing in IL neurons that project to the 




Inhibiting PFC-BLA projections impairs extinction memory recall 
 Thus far, our anatomical and physiological data implicate the IL-BLA pathway in 
extinction, but do not provide the kind of causal evidence for such a role that has been 
demonstrated by other studies.  To test this hypothesis, we used a dual virus chemogenetic 
approach to inhibit PFC outputs to the BLA (Figure 2.4a).  Infusion of HSV-mCherry-IRES-
Cre into the output region resulted in dense labeling in the PFC in KOR-DREADD (Figure 
2.4B) and ChR2-eYFP animals (Figure 2.4c). 
 In the PFC-BLA experiment, fear conditioning significantly increased freezing across 
CS-US pairings (F4,64=60.68, p<0.01), irrespective of virus group (Figure 2.4e).  Following 
Sal-B injection prior to extinction acquisition, freezing significantly decreased across trial-
blocks (F9,144= 13.48, p<0.01) in a manner that did not differ between virus groups (Figure 
2.4f).  However, on drug-free extinction retrieval the following day, freezing was significantly 
higher in the KORD group than in controls (t(8.77)=2.72 p=0.02) (Figure 2.4g). 
Discussion 
 The main findings of the current study were that IL neurons projecting to the BLA 
exhibited significant changes in intrinsic excitability following fear extinction acquisition, and 
that selectively chemogenetically inhibiting this pathway was sufficient to disrupt extinction 
memory formation.  The current results substantiate much of the findings of earlier studies that 
establish a critical contribution of the IL to fear extinction. 
 Employing techniques including immediate-early gene and molecular mapping, in vivo 
single-unit recordings, lesions, and IL-targeted pharmacological and optogenetic 
manipulations, a considerable body of work has shown that IL activity positively predicts 
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successful fear extinction, whereas functionally disrupting this region impairs extinction 
(Likhtik & Paz, 2015; Milad & Quirk, 2012; Rozeske et al., 2015; Tovote et al., 2015).  Of 
particular relevance to the current findings, Porter and colleagues have used ex vivo 
electrophysiological recordings to demonstrate changes in plasticity and the intrinsic 
excitability of IL neurons as a result of fear extinction (Cruz, Lopez, & Porter, 2014; Cruz et 
al., 2015; Santini, Quirk, & Porter, 2008).  Taken together with the current finding that there 
are similar changes in excitability in IL-BLA cells, these electrophysiological data suggest that 
extinction recruits IL neurons projecting to the BLA.  Indeed, this conclusion fits well with 
recent studies using neuronal tracing, electrophysiology and optogenetics to show that IL 
inputs directly innervate BLA neurons (Arruda-Carvalho & Clem, 2014; Strobel et al., 2015) 
to produce downstream changes in BLA plasticity (Cho et al., 2013a) that instruct extinction 
memory formation (Arruda-Carvalho & Clem, 2015; Bukalo et al., 2015a).  
 Another notable contribution of the current study lies in clarifying which outputs are 
not recruited by fear extinction.  By employing a dual retrograde tracer strategy, we observed 
that projections to the BLA are largely distinct from NAc projections, and may explain why 
fear extinction results in different electrophysiological responses in these populations. In this 
context, it has recently been shown that different outputs of the PFC become activated by 
positive and negative emotional experiences (Ye et al., 2016).  Given the well-established role 
for PFC-NAc projections in the extinction of cued drug seeking (Augur, Wyckoff, Aston-
Jones, Kalivas, & Peters, 2016; McFarland & Kalivas, 2001), it is reasonable to posit that this 
output is more actively involved in the extinction of appetitive behaviors.  It does bear noting 
that the retrograde tracing technique employed here did not label the entire BLA and NAc and 
thus, the number of CTB positive cells in the PFC is likely an underestimation of the number 
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of outputs to either region.  However, this experiment is not intended to provide an absolute 
measure of the number of projection neurons, but rather a measure of the relative size and 
overlap of these two populations.  The high degree of CTB labeling in layer 2/3 cortex is 
surprising, as layer 5 is canonically thought as the output layer of cortex.  Previous 
monosynaptic rabies tracing studies have, however, noted there are direct connections from 
layer 2/3 cortex to the striatum (Wall, De La Parra, Callaway, & Kreitzer, 2013), and this 
preferential labeling of layer 2/3 cortex has been observed in previous retrograde tracing 
studies of the PFC-BLA pathway (Cho, Deisseroth, & Bolshakov, 2013b). 
 There are several studies that, at first glance may seem to be odds with our findings.  
Specifically, when performing non-projection specific recordings in the IL, Santini and 
colleagues report a decrease in IL excitability following conditioning which is reversed by 
extinction (only to naïve levels).  Additionally, Cruz and colleagues have reported changes in 
IL intrinsic excitability exclusively starting at extinction consolidation (specifically, 4 hours 
after extinction), which are absent immediately after extinction.   However, these studies were 
performed in Sprague-Dawley rats, and thus it is possible that these differences are attributable 
to the difference in species.  Alternatively, as the current study used retrograde tracers to 
prospectively identify outputs to the BLA and NAc for recordings, the differences observed 
may be due to the specific population of neurons sampled.  Consistent with the findings of 
these two prior studies, we found decreased excitability in the IL-NAc pathway following fear 
conditioning that returns to naïve levels following extinction.  Given the fact that we observed 
slightly greater numbers of IL cells projecting to the NAc than the BLA, it is possible that the 
cells sampled by Santini et al. may have been weighted more heavily towards this population.  
This suppression and restoration of excitability in IL-NAc neurons may be consistent with a 
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model in which fear extinction restores the excitability of an appetitive pathway.  In addition 
to changes in excitability in the PFC, previous studies have noted that fear extinction results in 
decreased synaptic efficacy of PFC inputs to the BLA (Arruda-Carvalho & Clem, 2014; Cho 
et al., 2013b).  As we find increased excitability of PFC-BLA neurons following extinction, 
these findings suggest that it is possible that there is compartmentalization of plasticity events 
in cell body and terminals.  This will be an important question for future studies. 
 The current chemogenetic data provide an important confirmation and extension of 
recent work showing that optogenetically exciting IL projection neurons in the BLA or BMA 
promotes extinction, whereas silencing these cells impairs extinction (Adhikari et al., 2015; 
Bukalo et al., 2015a).  Through using a dual-virus system in which an HSV virus was injected 
directly into the BLA, taken up by terminals therein and retrogradely transported to the PFC 
for recombination with the KOR-DREADD virus, the current approach mitigates potential 
effects on BLA fibers of passage and demonstrates that PFC neurons terminating in BLA are 
necessary for extinction memory formation.    However, there are several important technical 
caveats to our findings.  First, because we gave Sal-B systemically, it is possible that the PFC 
neurons that project to the amygdala also project to other regions, and it is via actions in these 
other regions that disrupt extinction.  Unfortunately, the solubility of the KORD agonist 
precludes local infusion.  In addition, we did not include a vehicle control group.  However, 
we do not consider this a major concern, as the concentration of Sal-B we used does not cause 
changes in locomotion or have any anti-nociceptive properties (Ansonoff et al., 2006; Vardy 
et al., 2015).  Another methodological factor to point out is that there was an age difference in 
the mice used for the DREADD experiments (14 weeks) versus the mice used in the 
electrophysiology experiments (11 weeks).  Given the behavior of the mice in the two 
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experiments, these age differences are not likely to have impacted our conclusions.  Another 
potential confound with this issue is that using this dual virus approach, there was infection 
more broadly in PFC (IL and PL), as such, it is possible that this effect is due to a more general 
suppression of PFC outputs to BLA.  However, this concern is mitigated by our slice 
physiology data implicating the IL projections to the BLA.  Finally, the use of the agonist Sal-
B, which has a relatively short active duration (45-90 minutes) (Vardy et al., 2015), allowed 
the DREADD activation to be timed so that chemogenetic inhibition roughly corresponded 
with the length of the extinction session. However, it is possible that the results observed here 
are from continued inhibition of IL during extinction memory consolidation. Notably though, 
these data replicate the findings of Quirk and collegues (Do-Monte, Manzano-Nieves, 
Quinones-Laracuente, Ramos-Medina, & Quirk, 2015) whereby brief optogenetic inhibition 
of IL during extinction learning, but not extinction retrieval, impaired the expression of the 
extinction memory. Other groups have found opposing results though (Kim, Cho, Augustine, 
& Han, 2016), highlighting the need for future studies to more precisely refine the time course 
during IL is active during extinction learning and retrieval.  
 A number of interesting questions remain to be addressed in future work.  One 
important issue to clarify is the precise downstream targets of the IL inputs that subserve 
extinction.  This includes ascertaining the BLA neuronal populations and interneuron cell types 
that are directly innervated by the IL, as well as certain cell populations that neighbor, are 
tightly coupled to the BLA and have been implicated in extinction, particularly the intercalated 
cell clusters (Asede, Bosch, Luthi, Ferraguti, & Ehrlich, 2015; Busti et al., 2011; Cho et al., 
2013a; Jungling et al., 2008; Likhtik, Popa, Apergis-Schoute, Fidacaro, & Pare, 2008; Whittle, 
Hauschild, Lubec, Holmes, & Singewald, 2010).  In addition, recent data from Goosens and 
55 
 
colleagues suggests that extinction can specifically recruit BLA-NAc circuits to suppress fear 
reinstatement (Correia et al., 2016).  Moreover, optogenetic stimulation of BLA terminals in 
the NAc resulted in increased c-fos labeling in the IL, raising the possibility of an IL-BLA-
NAc feedback circuit that promotes extinction.  There is then the question of the origin of the 
inputs to the IL that drive extinction-related increases in neuronal excitability.  A good 
candidate for this is the BLA itself, based on recent evidence that BLA-IL and BLA-PL inputs 
exhibit functional changes that correlate well with extinction and fear, respectively (Senn et 
al., 2014; Sotres-Bayon, Sierra-Mercado, Pardilla-Delgado, & Quirk, 2012; Vogel et al., 2016).  
Thus, in light of the current findings and related data addressing the IL to BLA pathway, there 
would appear to be a bidirectional corticoamygdala circuit underlying extinction, rather than a 
simple ‘top-down’ (cortical to limbic) route that had been initially proposed. 
 In summary, the results of the current study offer further support for the importance of 
a neuronal circuit from the IL to the BLA in Pavlovian fear extinction.  By employing a variety 
of approaches, we were able to show that IL, but not PL, projection neurons innervating the 
BLA displayed an increase in the intrinsic excitability as a result of fear extinction.  In contrast, 
an anatomically distinct population of IL neurons projecting to the NAc did not exhibit such 
changes, however there appeared to be an extinction driven reversal of plasticity, in keeping 
with results from Porter and colleagues.  At the behavioral level, using DREADDs to 
selectively inhibit PFC-BLA neurons, we demonstrated the necessity of this pathway for 
extinction memory formation.  Collectively, these findings build on a growing literature 
establishing the critical contribution of the IL-BLA neural circuit to fear extinction.  Given the 




related disorders (Milad & Quirk, 2012; Shin & Liberzon, 2010), these current results help to 
illuminate understanding of the pathophysiology of these conditions and allow for further 




Figure 2.1 - Distinct Sets of mPFC Neurons Project to the BLA and NAc 
(a) The retrograde tracer CTB separately labeled with Alexa 488 and Alexa 555 was injected 
into the NAc and BLA.  (b) Representative image of injection sites in the BLA and NAc.  (c) 
Injection of tracers led to dense, but non-overlapping labeling of cells in the IL and PL.  (d) 
Quantification of fluorescent cells revealed dense, nonoverlapping labeling of BLA and NAc 
outputs throughout the PFC that was concentrated in the superficial layers of IL.  Scale bar 






Figure 2.2 - Extinction increases neuronal excitability in the IL-BLA, but not PL-BLA 
pathway 
(a) Retrobeads were injected into the BLA to visualize IL-BLA and PL-BLA projection 
neurons for electrophysiology recordings.  (b) Fear conditioning increased freezing across 
CS-US pairings.  (c) Fear extinction decreased freezing across CS trial-blocks.  In IL-BLA 
projection neurons, fear conditioning resulted in (d) increased resting membrane potential 
that was not present after extinction. In IL-BLA neurons, following extinction training there 
was also (e) higher action potential threshold, (f) lower rheobase, and (g) an increase in the 
number of action potentials fired across increasing current injections.  (Inset) Representative 
traces of current injected firing during the final step of an increasing current injection 
protocol.  In PL-BLA projections neurons, there were no differences in (h) resting membrane 
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potential, (i) action potential threshold, (j) rheobase, or (k) action potential number with 
increasing current injection magnitude.  Data presented are tests completed at resting 
membrane potential.  All data presented are mean ± SEM. Data were collected from N=6 
mice per group. In the infralimbic cortex there were n=8 cells per experiment in the naïve 
group, n=8 cells in the fear learning group, and n=10 cells in the fear extinction group. In the 
prelimbic cortex, there were n=8 cells per experiment in the naïve group, n=5 cells in the fear 





Figure 2.3 - Extinction does not increase neuronal excitability in the IL-NAc or PL-NAc 
pathways. 
(a) Retrobeads were injected into the NAc to visualize IL-NAc projection neurons for electrophysiology 
recordings.  (b) Fear conditioning increased freezing across CS-US pairings.  (c) Fear extinction 
decreased freezing across CS trial-block.  In IL-NAc projection neurons, there were no differences 
following fear conditioning or fear extinction in (d) resting membrane potential, (e) action potential 
threshold, or (f) rheobase.  (g) There was a significant reduction in the number of action potentials fired 
in the fear conditioning group when recordings were performed at -70mV, but was not present when 
performed at resting membrane potential.  In PL-NAc projections neurons, there were no differences 
in (h) resting membrane potential, (i) action potential threshold, (j) rheobase, or (k) action potential 
number with increasing current injection magnitude.  All data presented are mean ± SEM.  Data were 
collected from N=4 mice per group. In the infralimbic cortex, there were n=8 cells per experiment in 
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the naïve group, n=6 cells in the fear learning group, and n=8 cells in the fear extinction group. In the 
prelimbic cortex, there were n=9 cells per experiment in the naïve group, n=6 cells in the fear learning 







Figure 2.4 - Chemogenetic inhibition of IL-BLA projections impairs long-term extinction 
memory formation.   
(a) HSV was injected into the BLA and KORD or a control virus was injected into the IL to 
selectively inhibit IL-BLA projections.  Representative images of (b) KORD and (c) eYFP 
expression in the IL.  (d) Mice were fear conditioned on day 1, then injected with Sal-B prior 
to extinction acquisition on day 2 and tested, drug-free, for extinction retrieval on day 3.  
Bottom row, PFC-BLA behavior cohort: (e) Fear conditioning increased freezing across CS-




IL-BLA inhibition.  (g) IL-BLA inhibition during extinction acquisition impaired extinction 
memory retrieval.  All data presented are mean ± SEM.  N=8 KORD mice and N=10 
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CHAPTER 3: KAPPA OPIOID AND DYNORPHIN SIGNALING IN THE CENTRAL 
AMYGDALA REGULATES ALCOHOL INTAKE 
Introduction 
Excessive alcohol drinking is a serious public health problem and was estimated to cost 
the United States over $249 billion in 2010 (Sacks, Gonzales, Bouchery, Tomedi, & Brewer, 
2015). The majority of these expenses could be attributed to binge drinking, a form of alcohol 
consumption wherein individuals imbibe large amounts of alcohol within a short period of time 
and reach blood alcohol concentrations above 0.08% (80mg/dL) (NIAAA). Individuals who 
engage in frequent binge drinking have a higher risk of later developing Alcohol Use Disorder 
(AUD) (Jennison, 2004; McCarty et al., 2004), and binge alcohol consumption has been shown 
to engage the neural circuitry involved in the addiction cycle. Specifically, withdrawal from 
alcohol has been shown to engage the extended amygdala, a limbic brain circuit principally 
comprised of the central nucleus of the amygdala (CeA) and the Bed Nucleus of the Stria 
Terminalis (BNST) (Alheid & Heimer, 1988). These regions are important for regulating 
negative affective states, which are thought to underlie the negative reinforcing properties of 
alcohol (Koob & Le Moal, 2005).  
Abundant within these brain regions is the kappa opioid receptor (KOR) and its 
endogenous ligand dynorphin (PDYN). Activation of KOR results in dysphoria in human 
subjects (Pfeiffer et al., 1986), and recently it has been shown that there is reduced KOR 
occupancy in the amygdala of patients with an alcohol use disorder (Vijay et al., 2018). In 
animal models, systemic treatment with KOR antagonists has been shown to reduce ethanol 
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self-administration (B. M. Walker & Koob, 2007), stress-enhanced drinking (Anderson, 
Lopez, & Becker, 2016), and ethanol dependence-induced increases in anxiety (Valdez & 
Harshberger, 2012). Additionally, it has been shown that site-specific KOR antagonism in the 
CeA decreases ethanol self-administration in dependent animals (Kissler et al., 2014) and 
alcohol consumption in a model of binge-like drinking (Anderson et al., 2018). Anderson et 
al. also found that chemogenetic inhibition of CeA dynorphin neurons was capable of reducing 
binge-like drinking, suggesting that the source of dynorphin release may be within the CeA. 
However, one limitation of these experiments is that dynorphin neurons co-express a variety 
of other neuropeptides such as corticotropin releasing factor, somatostatin, and neurotensin (J. 
Kim et al., 2017). Thus, it is unclear whether the results of the chemogenetic experiment are 
due directly to dynorphin release or some other co-expressed neuropeptide. 
To examine more closely how this system may work to regulate ethanol consumption, 
we performed dual in situ hybridization of PDYN and KOR and found that they were expressed 
in separate, non-overlapping neuronal populations in the CeA. We then selectively knocked 
out PDYN and KOR, and found that these manipulations resulted in reductions in alcohol 
drinking in a sex-specific manner. Finally, we performed slice electrophysiology recordings 
from mice that underwent binge-like drinking and found that a history of alcohol drinking 
resulted in sex-specific alterations in PDYN neuron excitability.   
Materials and Methods 
Subjects 
 Experiments were performed on adult male and female mice between 8-10 weeks at 
the beginning of the experiments. Preprodynorphin-IRES-Cre and Rosa26-loxSTOPlox-L10-
70 
 
GFP (Krashes et al., 2014), Floxed KOR conditional knockout mice (Chefer, Bäckman, 
Gigante, & Shippenberg, 2013) were generated as described previously and bred in house at 
UNC. Additionally, Floxed PDYN mice were generated as described below (Palmiter Lab), 
and were subsequently transferred and bred in house at UNC. All mice were group housed in 
colony rooms on a 12:12 hr light-dark cycle (lights on at 7 a.m.) with ad libitum access to 
rodent chow and water. All animal procedures were performed in accordance with the 
Institutional Animal Care and Use Committee at the University of North Carolina at Chapel 
Hill. 
Generation and Validation of PDYN-Flox Conditional Knockout Mice 
The 5’ arm of the targeting construct (3.8 kb) was PCR amplified from a C57Bl/6 BAC 
clone using Q5 DNA polymerase with Pac1 site at the 5’ end and Xba1 site at the 3’ end 
(Supplementary Figure 2a). A synthetic loxP site was inserted into the BamH1 site 5’ of the 
first coding exon. The 3’ arm of the targeting construct (3.05 kb) was PCR amplified with Sal1 
site at the 5’ end and Not1 site at the 3’ end.  The two arms were cloned into the polylinkers of 
a targeting vector with a loxP site, a frt-flanked SV40-neomycin resistance gene for positive 
selection, Pgk-DTa and HSV-TK genes for negative selection.  The targeting construct was 
electroporated into G4 ES cells and correct targeting was established by Southern blot of DNA 
digested with Bcl1 using a 32P-labelled probe located beyond the 3’ arm of the targeting 
construct. Seven of 60 clones were correctly targeted and all of them retained the distal loxP 
site assessed using PCR primers (5’ GACTCACTTGTTTGCTGGAGAG and 5’ 
CAGAGTACGTGGATTGTCACAG) flanking the distal loxP site.  Several clones were 
injected into blastocysts of C57Bl/6J mice and then transferred to pseudo-pregnant females.  
One of the clones that gave high percentage of chimeric mice, was bred with mice expressing 
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FLP recombinase to remove the NeoR gene.  The mice were then continuously backcrossed to 
C57BL/6 mice.  Routine genotyping was performed using the primers indicated above.  
Stereotaxic Surgeries 
 Mice were anesthetized with 4% isoflurane and placed in a stereotaxic frame (Kopf 
Instruments, Tujunga, CA, USA) and maintained under 1-2% isoflurane for the duration of the 
surgery. The skull was exposed and burr holes were made with a drill over the coordinates of 
the Central Amygdala (M/L +/- 2.90, A/P -1.20, D/V -4.70). A Hamilton Syringe (Hamilton 
Company, Reno, NV) was used to deliver 200 nL of an adeno associated viruses encoding cre 
recombinase (AAV5-CamKIIa-Cre-eGFP) or control (AAV5-CamKII-eGFP) into the CeA. 
The virus was infused at a rate of 0.1 μL per minute and left in place for at least 5 minutes to 
ensure diffusion. 
Histology 
 Following the completion of behavioral experiments, mice were deeply anesthetized 
with an overdose of tribromoethanol (250 mg/kg, intraperitoneal) and transcardially perfused 
with 0.01 M phosphate buffered saline (4°C, pH 7.4) followed by 4% paraformaldehyde in 
PBS.  Brains were post-fixed for 24 hours in 4% PFA and then cryoprotected in 30% sucrose 
in PBS. Coronal sections containing the CeA were cut at a thickness of 45 μm using a 
Vibratome (Leica VT1000S, Buffalo Grove, IL, USA) and stored in a 50% glycerol/PBS 
solution. 
In Situ Hybridization 
Mice were anesthetized with isoflurane and rapidly decapitated. Brains were dissected 
and flash frozen on dry ice for 15 min and stored at -80°C until sectioned for in situ 
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hybridization (ISH). Brain slices (16 µm) containing the CeA were obtained on a Leica CM 
3050S cryostat (Leica Biosystems, Nussloch, Germany) at -20°C and were mounted directly 
onto microscope slides. Slides were stored at -80°C until tissue was processed for ISH. 
RNAscope ISH was conducted using the Multiplex Fluorescence Assay following the 
manufacturer’s protocol (Advanced Cell Diagnostics, Newark, CA, USA). Briefly, slides were 
fixed in 10% neutral buffered formalin for 15 min at 4°C. Slides were subsequently washed 
twice for 5 min with PBS, before dehydration with 50% ethanol (1 x 5 min), 70% ethanol (1 x 
5 min), and 100% ethanol (2 x 5 min). The slides were allowed to dry at room temperature for 
3-5 minutes. A hydrophobic barrier was then drawn around the sections using a hydrophobic 
pen and allowed to dry for 10-15 min at RT. Sections were then incubated with Protease 
Pretreat-4 solution for 15 min at RT. Slides were washed by moving the slide tray up and down 
in PBS 2 x 5 times. The slides were then incubated with the appropriate probes for 2 hr at 40°C 
in a HybEZ oven (Advanced Cell Diagnostics). Probes used were purchased from Advanced 
Cell Diagnostics and are as follows: PDYN-C1 (Accession number NM_018863.3), OPRK1-
C2 (Accession Number NM_001204371.1), and EGFP-C1 (Accession Number U55763.1). 
Slides were washed in wash buffer twice for 2 min, prior to being incubated with Amplification 
1 buffer at 40°C in the HybEZ oven for 30 min. Slides were subsequently washed in wash 
buffer twice for 2 min, then incubated with Amplification 2 buffer at 40°C in the HybEZ oven 
for 15 min. Slides were washed in wash buffer twice for 2 min, prior to being incubated with 
Amplification 3 buffer at 40°C in the HybEZ oven for 30 min. Slides were subsequently 
washed in wash buffer twice for 2 min, and incubated with Amplification 4-Alt C buffer at 
40°C in the HybEZ oven for 15 min. Slides were washed in wash buffer twice for 2 min. 
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Finally, slides were coverslipped with ProLong Gold Mounting Medium containing DAPI 
(Fisher Scientific, Pittsburgh, PA, USA) and stored at 4°C. 
Microscopy 
 Correct placements for viral infusions were verified using a wide-field epifluorescent 
microscope (BX-43, Olympus, Waltham, MA, USA) using a stereotaxic atlas (Franklin & 
Paxinos, 2008).  Images for the quantification of fluorescent in situ hybridization were 
collected on a Zeiss 800 Laser Scanning Confocal Microscope (20x objective, NA=0.8) (Carl 
Zeiss, Jena, Germany).  Regions of Interest (ROIs) containing the Central Lateral (CeL) and 
Central Medial (CeM) were annotated using Zeiss Zen 2 Blue Edition software. Manual 
quantification of PDYN positive and KOR positive cells was performed using manual counts 
with the cell counter plugin in FIJI (Curtis Rueden, LOCI, University of Wisconsin-Madison, 
Madison, WI, USA).  
qPCR on Tissue Punches 
Mice were anesthetized with isoflurane and rapidly decapitated. The brain was 
dissected out and 1 mm coronal sections were made using a brain block. Slices were flash 
frozen on dry ice and tissue punches containing bilateral samples from the CeA were taken and 
stored at -80°C until future use. Total RNA from tissue punches was extracted using Direct-
zol RNA miniprep kit (Zymo Research, Irvine, CA, USA). Reverse transcription and qPCR 
were performed using Superscript II and Applied Biosystems Taqman Assay on a StepOnePlus 
Real Time PCR System (Thermo Fisher Scientific, Waltham, MA, USA). The following 
TaqMan assay probes were purchased from Invitrogen (USA): ACTB Mm00607939_s1, 
OPRK1 Mm01230885_m1, PDYN Mm00457573_m1. 
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Alcohol and Tastant Drinking Procedures 
All alcohol and tastant drinking experiments were conducted with mice single housed 
in a reverse light cycle space (lights off at 7am, lights on at 7am). For the duration of all 
experiments, mice were maintained on an Isopro RMH 3000 (LabDiet, St. Louis, MO, USA) 
diet, as this been shown to result in the highest levels of ethanol consumption (Marshall et 
al., 2015). All animals were transferred to the reverse light space to acclimate to the chow 
and light cycle for at least one week prior to the start of experiments.  
Drinking in the Dark (DID) was carried out using procedures described previously 
(Lowery-Gionta et al., 2012; Pleil, Rinker, et al., 2015; Rhodes, Best, Belknap, Finn, & 
Crabbe, 2005). Briefly, on days 1–3 beginning 3 hours into the dark cycle, water bottles were 
removed from all cages and replaced with a bottle containing 20% (v/v) ethanol solution. 
Mice had 2 hrs of access to ethanol, after which the ethanol bottles were removed from cages 
and water bottles were replaced. The same procedure was followed on day 4 except that 
ethanol access was extended to 4 hrs. Bottle weights were recorded after 2 and 4 hrs of 
access to ethanol on day 4. Additionally, a bottle was placed on an empty cage during all 
experiment days in order to record the amount of volume loss due to ethanol drip alone. This 
value was generally less than 0.1 mL/ 2 hrs and was subtracted from the raw daily intake. 
The difference in start and end bottles weights minus the drip value was corrected for the 
density and concentration of ethanol and divided by the mouse’s body weight to obtain 
normalized intake g/Kg. Days 1-4 comprised one cycle of DID which was repeated for a total 
of 4 wks at which point we have previously demonstrated dynorphin and KOR modulation of 
binge-like drinking in the CeA (Anderson et al., 2018). 
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Following completion of DID experiments, cage tops were replaced with lids 
designed for 2-bottle drinking. Following 3 days of acclimation to bottles containing only 
water, animals began Intermittent Access to Ethanol (IA) as described previously (Hwa et al., 
2011). Briefly, on Monday, Wednesday, and Friday mornings 3 hrs into the dark cycle, one 
of the water bottles was replaced with 20% ethanol (w/v). Animals then had access to the 
ethanol for 24 hrs at which point the difference in weights of the water and ethanol bottles 
was measured. Drip values for water and ethanol bottles were calculated separately and used 
to calculate normalized consumption using the method described above. The side of the 
ethanol bottle (left or right) was counterbalanced across session to prevent the development 
of a side preference. Animals underwent IA for 2 wks to assess the effects of the genetic 
knockout on total fluid consumption and alcohol preference. 
Ethanol naïve animals underwent drinking of aversive or palatable solutions using the 
same procedures as the drinkers. However, the animals always had access to one bottle 
containing water and the other containing the tastant solution of interest. The concentrations 
of quinine (0.3, 0.6, and 0.9 mM), saccharin (0.33% and 0.66%), and sucrose (1%) were 
chosen based on values previously used to characterize global PDYN and KOR knockout 
mice (Blednov, Walker, Martinez, & Harris, 2006; Kovacs et al., 2005). The bottles for the 
tastant solution were changed 3 hrs into the dark cycle and the animals had access to each 
solution for 24 hrs thereafter. The weight of the tastant bottles and the drip bottles were 
recorded the following day and replaced on the opposite side as the previous day. The 
difference in consumption was averaged across the two days to obtain a single value for the 
preference of each solution. The bottle choice assay began with the lowest concentration of 
tastant in the series (0.3 mM quinine or 0.33% saccharin), which was then increased over the 
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course of the next 6 days. This was then followed by 2 days of washout during which only 
water was available. Then began the preference test with the lowest concentration of the next 
series of solutions. The order of presentation of each solution type (palatable or aversive) was 
counterbalanced across cohorts within an experiment.  
Elevated Plus Maze 
The Elevated Plus Maze (EPM) (Med Associates, St. Albans, VT) was made of 
white-and-black plastic and consisted of two open arms (75 × 7 cm) and two closed arms (75 
× 7 × 25 cm) adjoined by a central area (7 × 7 × 25 cm). The arms were arranged in a plus 
configuration with arms of the same type (open or closed) opposite of each other. The maze 
was elevated 75 cm with light levels maintained at 15 lux throughout the experiment. Mice 
were placed in the center of the EPM and allowed to explore freely. The EPM was cleaned 
with 70% ethanol between each trial. Movements were video recorded and analyzed using 
Ethovision 9.0 (Noldus Information Technologies). The primary measures of reduced 
anxiety-like behavior were time spent in the open arm and number of entries into the open 
arm. 
Slice Electrophysiology  
We performed whole-cell electrophysiology experiments similar to those published 
previously (Crowley et al., 2016; Lowery-Gionta et al., 2012). Briefly, 300 µm coronal slices 
containing the CeA were prepared on a vibratome (Leica VT1200, Leica, Wetzlar, Germany) 
from mice rapidly decapitated under isoflurane. The brains were removed and placed in ice-
cold modified high sucrose artificial cerebrospinal fluid (aCSF) containing the following (in 
mM): 194 sucrose, 20 NaCl, 4.4 KCl, 2 CaCl2, 1 MgCl2, 1.2 NaH2PO4, 10.0 glucose, and 
26.0 NaHCO3. Slices were then transferred to normal aCSF maintained at approximately 
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30°C (Warner Instruments, Hamden, Connecticut) containing the following (in mM): 124 
NaCl, 4.4 KCl, 2 CaCl2, 1.2 MgSO4, 1 NaH2PO4, 10.0 glucose, and 26.0 NaHCO3. Slices 
were placed in a holding chamber where they were allowed to rest for at least one hour. 
Slices were continuously bubbled with a 95% O2 / 5% CO2 mixture throughout slicing and 
experiments. Thin-walled borosilicate glass capillary recording electrodes (3–6 MΩ) were 
pulled on a Flaming-Brown micropipette puller (Sutter Instruments, Novato, CA).  
Following rupture of the cell membrane, cells were allowed to rest and equilibrate to 
the intracellular recording solutions (below). Signals were acquired via a Multiclamp 700B 
amplifier (Molecular Devices, Sunnyvale, California), digitized at 10 kHz and filtered at 3 
kHz. Current clamp experiments were analyzed using Clampfit 10.2 software (Molecular 
Devices) and spontaneous synaptic transmission experiments were analyzed using Mini 
Analysis version 6.0.7 (Synaptosoft, Decatur, GA). Access resistance was monitored 
continuously throughout the experiment, and when it deviated by more than 20% the 
experiment was discarded. No more than two cells per animal were included in each 
experiment. For current clamp experiments, cells were recorded using a potassium-gluconate 
based internal recording solution containing the following (in mM): 135 K-gluc, 5 NaCl, 2 
MgCl2, 10 HEPES, 0.6 EGTA, 4 Na2ATP, 0.4 Na2GTP. Experiments were conducted both at 
resting membrane potential (RMP) and -70mV.  
Lidocaine N-ethyl bromide (1 mg/mL) was included in the intracellular recording 
solution to prevent postsynaptic sodium spikes for all voltage-clamp experiments. For 
voltage-clamp experiments requiring the simultaneous recording of excitatory and inhibitory 
events within the same neuron, a cesium-methanesulfonate based intracellular recording 
solution containing the following (in mM) was used: 135 Cs-meth, 10 KCl, 1 MgCl2, 0.2 
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EGTA, 4 MgATP, 0.3 GTP, 20 phosphocreatine.  Excitatory events were recorded at -55mV 
and inhibitory events were recorded at +10mV. 
Data Analysis and Statistics 
Data are displayed as means ± SEM. For changes in the proportion of overlapping 
PDYN and KOR neurons after alcohol drinking, groups were compared with a test. Changes 
in mRNA expression were compared with a two-sample t test with Welch’s correction. 
Alcohol consumption and preference were analyzed as within subjects repeated measures 
ANOVA. Measures of anxiety-like behavior in the elevated plus maze were compared with a 
two-way (alcohol treatment X gene knockout) factorial ANOVA. Changes in synaptic 
transmission and excitability were assessed with either a repeated measures ANOVA or a 
two-sample t test with Welch’s correction where appropriate. All analyses were performed 
with R statistical software version 3.3.2.  
Results 
PDYN and KOR Expressing Neurons Form Separate Populations in the CeA and The 
Expression of Which is Not Altered Following Alcohol Drinking 
Many studies have implicated the role of peptidergic signaling in the central 
amygdala as an important locus for regulating both dependent and non-dependent forms of 
alcohol drinking (Funk, O’Dell, Crawford, & Koob, 2006; Lowery-Gionta et al., 2012; 
Sparrow et al., 2012). Indeed, it has been shown that antagonizing KOR (Kissler et al., 2014)  
and chemogenetically inhibiting PDYN neurons (Anderson et al., 2018) can both decrease 
alcohol consumption. Despite evidence showing that both PDYN and KOR are expressed in 
the CeA, the circuit mechanism underlying this effect remains unclear. To assess the 
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expression of PDYN and KOR, and how it may be affected by a history of alcohol drinking, 
we ran C57BL/6J mice through three cycles of Drinking in the Dark (DID). Eight hours after 
the final binge session, animals were sacrificed for in situ hybridization and qPCR 
experiments (Figure 3.1a). Interestingly, we found that PDYN and KOR were expressed on 
relatively separate populations of neurons, and that the proportion of PDYN+, KOR+, and 
colocalized neurons was unaltered by ethanol drinking (Figure 3.1b-c). Additionally, PDYN 
and KOR gene expression levels were not changed following DID (Figure 3.1d). These 
findings suggest that although PDYN and KOR may be involved in the regulation of alcohol 
consumption, their mRNA levels are unaffected by a history of alcohol drinking. 
CeA KOR Knockout Reduces Alcohol Consumption and Preference in a Sex-Specific Manner 
Previous studies employing pharmacological approaches have shown that KOR 
antagonism in the CeA can decrease alcohol intake (Anderson et al., 2018; Kissler et al., 
2014). However, it remains unclear whether this is mediated by KORs on CeA neurons or on 
presynaptic terminals from other brain regions. To establish a casual role for KOR signaling 
in CeA neurons, we performed a conditional knockout of KOR in young adult male and 
female mice. Floxed KOR mice (Chefer et al., 2013) were infused with an AAV encoding 
Cre recombinase or control fluorophore (Figure 3.2a-b). Alcohol drinking experiments began 
three weeks after virus injection, at which time point we have previously demonstrated that 
there is a sufficient knockout of KOR (Crowley et al., 2016). As predicted by the findings of 
Anderson et al. (2018), knockout of KOR on CeA neurons in male mice resulted in a 
significant reduction in the amount of alcohol consumed across 4 wks of DID (Figure 3.2d-f). 
Because global KOR knockout has previously been shown to alter fluid intake levels 
(Kovacs et al., 2005), we wanted to examine whether the differences in DID observed were 
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due to overall reductions in fluid intake. Immediately following completion of DID, 
experimental bottles were replaced for Intermittent Access to Ethanol (IA) so that changes in 
water consumption and ethanol preference could also be measured. Notably, reductions in 
alcohol drinking in KOR knockout mice were observed throughout the duration of IA 
experiments (Figure 3.2g). Additionally, knockout animals had significantly lower ethanol 
preference, but no significant differences in the amount of total fluid consumed (Figure 3.2h-
j).  
Most studies on KOR regulation of drug self-administration to date have largely been 
conducted with male animals. While KOR systemic antagonism has generally resulted in 
reductions in drinking in male animals (Anderson & Becker, 2017), some experiments in 
female animals have observed that KOR antagonism does not alter alcohol consumption (Zhou, 
Crowley, Ben, Prisinzano, & Kreek, 2017). Moreover, KOR activation is less aversive to 
female animals (Russell et al., 2014) suggesting that there may be sex differences in KOR 
function. Interestingly, KOR knockout female mice did not exhibit the reductions in alcohol 
drinking in DID observed in their male littermates (Figure 3.2k-m). Additionally, there were 
no significant differences in total fluid consumption or ethanol preference observed between 
wild type and knockout animals during IA (Figure 3.2n-q). Thus, it appears that reductions in 
alcohol drinking previously demonstrated in female global KOR knockout animals (Kovacs et 
al., 2005; Van’t Veer, Smith, Cohen, Carlezon, & Bechtholt, 2016) are likely mediated outside 
the CeA. 
CeA KOR Knockout Does Not Alter the Palatability of Appetitive or Aversive Tastants 
One possible explanation for the reductions in alcohol drinking observed in the male 
KOR knockout mice is that the experimental manipulation may render the taste of ethanol 
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more aversive to knockout animals. If this were the case, the changes observed would be due 
to alterations in taste perception rather than the pharmacological actions of ethanol. Contrary 
to this hypothesis, global KOR knockout animals have been observed to have increased 
preference for the aversive tastant quinine (Kovacs et al., 2005). However, to rigorously 
address this possibility, we examined the preference of a separate group of ethanol naïve wild 
type and CeA KOR knockout animals for a range of palatable and aversive tastant solutions 
(Figure 3.3a).  We did not observe any significant differences in the quinine preference of 
male or female animals for the range of concentrations tested (Figure 3.3b,e). Additionally, 
we did not observe any differences in the preferences for saccharin, a non-caloric sweetener, 
or sucrose, a caloric sweetener (Figure 3.3c,f). One other possibility to consider is that 
ethanol is a source of calories and the reductions in ethanol consumption in KOR knockout 
animals are secondary to changes in overall metabolic intake. To assess the effects of KOR 
knockout on the consumption of a caloric reinforcer, we performed binge access to 10% 
sucrose as described previously (Pleil, Rinker, et al., 2015; Rinker et al., 2017). We did not 
find any effect of KOR knockout on binge consumption of sucrose in male or female mice 
(Figure 3.3d,g). 
CeA PDYN Knockout Reduces Alcohol Consumption and Preference in a Sex-General Manner 
One question arising from the previous experiment is where is the source of the 
endogenous dynorphin that mediates the reduction of alcohol drinking observed in male 
mice. Given the large adjacent population of PDYN+ neurons, one likely possibility to 
consider is that the dynorphin acting on CeA KORs may be released locally. Indeed, 
Anderson et al. (2018) demonstrated that chemogenetic inhibition of CeA dynorphin neurons 
decreases binge alcohol consumption in male animals. However, one limitation of this 
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experiment is that CeA dynorphin neurons co-express a variety of other neuropeptides 
including somatostatin, corticotropin releasing factor, and neurotensin (J. Kim et al., 2017). 
As each of these neuropeptides may have their own effect on alcohol drinking, it is unclear 
whether the results observed are directly due to dynorphin release. As no mouse line 
presently existed to manipulate dynorphin expression in a conditional manner, we generated 
a PDYN-Flox line to allow for selective knockout of PDYN in the CeA. A recombinant 
plasmid targeting the endogenous PDYN gene was generated (Figure 3.4a), and chimeric 
mice were selectively bred as described in the experimental methods section. Validation with 
in situ hybridization showed that viral expression of cre recombinase resulted in a significant 
reduction in the number of PDYN+ nuclei (Figure 3.4b-f), confirming that the PDYN-Flox 
line is an effective tool for manipulating PDYN gene expression in the CeA. 
To directly examine the effects of dynorphin signaling on alcohol drinking behavior, 
we performed conditional knockout in the PDYN in the CeA following the same timeline as 
what was used in the KOR knockout experiments (Figure 3.5a). As PDYN knockout would 
have the same net effect on the proposed circuit as the KOR knockout (Figure 3.5b), we 
hypothesized there would be a similar reduction in alcohol drinking in male mice. In 
concordance with the results from the previous experiment, we observed that PDYN 
knockout resulted in a significant reduction in ethanol consumption across four weeks of 
DID (Figure 3.5d-f). Additionally, this reduction in alcohol drinking was observed 
throughout the two weeks of IA and did not significantly alter overall fluid intake (Figure 
3.5g,h). One notable divergence from the KOR knockout is that PDYN knockout did not 
significantly reduce ethanol preference (Figure 3.5i). However, any difference may be 
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obscured by a floor effect, as the PDYN-Flox control animals had considerably lower 
preference than KOR-Flox control animals. 
We next wanted to test whether CeA PDYN knockout would result in similar 
reductions in female mice, or if there would be a divergent response between sexes as was 
observed with KOR knockout.  Thus, we deleted PDYN in CeA of female mice following the 
same timeline as before.  We observed that CeA PDYN lowered, but did not significantly 
reduce, ethanol consumption during DID (Figure 3.5k-m). However, PDYN knockout did 
significantly reduce alcohol consumption during IA in females (Figure 3.5n) and reduced 
ethanol preference without affecting overall fluid intake (Figure 3.5o,p). Thus, it appears that 
CeA PDYN knockout does play some role in regulating ethanol consumption in female mice. 
CeA PDYN Knockout Does Not Alter the Palatability of Appetitive or Aversive Tastants 
Previously, it has been demonstrated that global PDYN knockout animals have 
significantly altered fluid intake, saccharin preference, quinine preference, and sucrose 
consumption compared to littermate controls (Blednov et al., 2006). To assess the effects of 
CeA PDYN knockout on each of these parameters, ethanol naïve mice underwent tastant 
drinking experiments following the same timeline as KOR knockout experiments (Figure 
3.6a). In contrast to what was observed in the PDYN global knockout animals, CeA PDYN 
knockout in male mice did not alter quinine, saccharin, or sucrose preference (Figure 3.6b,c). 
Additionally, PDYN knockout did not alter binge consumption of a 10% sucrose solution 
(Figure 3.6d). Similarly, PDYN knockout in female mice did not have an effect on the 
preference of any of the tastant solutions (Figure 3.6e,f) or limited access consumption of 
sucrose (Figure 3.6g). Thus, it is likely that CeA PDYN knockout selectively alters the drive 




KOR and PDYN Knockout Do Not Protect Against Alcohol Drinking Induced Increases in 
Anxiety 
A history of alcohol drinking is thought to lead to a new allostatic set point wherein 
consumption of alcohol alleviates the negative emotional state induced by alcohol 
withdrawal. This removal of an aversive state, termed negative reinforcement, is mediated by 
the extended amygdala (Koob & Moal, 1997). Ethanol dependence has been shown to 
increase anxiety-like behavior in the elevated plus maze, which can be reversed by systemic 
treatment with a KOR antagonist (Valdez & Harshberger, 2012). If PDYN or KOR knockout 
is protective against the negative reinforcing properties of ethanol, these manipulations 
should produce a detectable change in anxiety-like behavior during acute withdrawal. 
Because KOR knockout decreases ethanol consumption, we examined the effects of KOR 
knockout in ethanol naïve animals and those with a history of alcohol drinking (Figure 3.7a). 
We observed that there was a main effect of alcohol drinking whereby a history of alcohol 
use increased anxiety-like behavior in the EPM in male mice (Figure 3.7bc). However, there 
was no main effect or interaction with genotype, indicating that KOR knockout does not alter 
anxiety in the basal state or during withdrawal. Similar effects were observed in female mice, 
as there was a main effect of alcohol drinking on open arm entries, but no main effect or 
interaction with genotype (Figure 3.7f). With PDYN knockout, we did not observe any 
effects of ethanol drinking or gene knockout on open arm time or entries (Figure 3.7h-i). 
However, ethanol drinkers had significantly higher locomotion than naïve controls (Figure 
3.7j). In female mice, there was no effect of PDYN knockout or ethanol drinking on open 
arm time, open arm entries, or total distance traveled (Figure 3.7k-m).  
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A History of Ethanol Drinking Does Not Alter Spontaneous Synaptic Transmission onto CeA 
PDYN Neurons 
Previously it has been shown that a history of alcohol exposure can alter the balance 
of spontaneous synaptic transmission in the CeA (Pleil, Lowery-Gionta, et al., 2015). To 
assess the mechanism by which CeA KOR and PDYN knockout may be protective against 
escalations in alcohol drinking, we assessed the effects of binge-like alcohol drinking on 
endogenous CeA PDYN neuron physiology. In these experiments, male and female PDYN-
IRES-Cre-Rosa26-L10-eGFP reporter mice underwent three cycles of DID with access to 
20% ethanol or water. The timing of alcohol exposure was staggered so that 
electrophysiology recordings were performed 24 hours hrs after the final binge session. In 
male mice, we did not observe any effect of alcohol drinking on either the frequency or 
amplitude of excitatory or inhibitory transmission (Figure 3.8a-d). Spontaneous synaptic 
transmission in female mice was also unaffected by alcohol drinking (Figure 3.8e-h). These 
experiments suggest that the protective effects of PDYN/KOR knockout are likely not 
mediated by altering the balance of excitatory and inhibitory transmission in the CeA. 
Ethanol Drinking Results in Sex-Specific Changes in Intrinsic Excitability of CeA Dynorphin 
Neurons 
Alcohol exposure has been shown to result in cell-type specific changes in the 
excitability of CeA neurons (Herman, Contet, & Roberto, 2016). To assess whether alcohol 
drinking may alter cell intrinsic excitability, we examined whether a history of alcohol 
drinking altered the firing properties of CeA PDYN neurons. In these experiments, PDYN-
IRES-Cre-Rosa26-L10-eGFP reporter mice underwent DID with 20% ethanol or water as 
described previously. In male mice, ethanol drinking did not alter the resting membrane 
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potential, action potential threshold, or rheobase of PDYN neurons (Figure 3.9a-c). However, 
there was a non-significant trend to increased number of action potentials fired to increasing 
steps of depolarizing current (Figure 3.9d). Resting membrane potential, action potential 
threshold, and rheobase in female mice was similarly unaltered after alcohol exposure 
(Figure 3.9e-g). However, there was a significant reduction in the number of action potentials 
fired in a voltage versus current plot (Figure 3.9h). These experiments demonstrate that a 
history of alcohol drinking changes the excitability of PDYN neurons in opposing directions 
in male and female mice, which may partially explain the divergent results seen with in vivo 
manipulations. 
Discussion 
Despite its high prevalence, there remain only three FDA approved 
pharmacotherapies available to treat AUD (Heilig & Egli, 2006). One of these therapies, 
naltrexone, works as a non-specific opioid antagonist. Recently there has been an interest in 
developing KOR-specific antagonists to treat AUD as well as other psychiatric conditions 
(Carroll & Carlezon, 2013; Charles Chavkin & Koob, 2016; Crowley & Kash, 2015). 
However, in order to achieve targeted interventions, it is important to understand how 
alcohol drinking modulates PDYN/KOR circuitry. The present study sought to address this 
by mechanistically dissecting how PDYN and KOR signaling in the CeA contribute to 
excessive alcohol intake. We observed that PDYN and KOR form spatially adjacent, but 
non-overlapping populations suggesting that the balance of these two cell types may control 
the balance of different outputs. We then performed separate knockouts of PDYN and KOR 
and found that while knockout of PDYN decreased alcohol consumption in both sexes, 
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knockout of KOR resulted in reductions of alcohol intake in male mice only. Finally, we 
found sex-specific reductions in PDYN neuron excitability in female mice following alcohol 
drinking. 
There were also several important nuances to our findings. The first is that the 
mechanism of protective action of PDYN/KOR knockout is likely different between sexes. 
The fact that CeA KOR knockout did not affect alcohol drinking in female mice may not be 
surprising though given that KOR activation has been shown to be less aversive to female 
animals (Russell et al., 2014). However, it should be noted that female KOR global knockout 
animals showed reduced ethanol consumption and preference comparable to their male 
counterparts (Kovacs et al., 2005). In the present study, the results in female mice were not 
entirely negative as PDYN knockout produced a significant reduction in ethanol 
consumption and preference in IA. Thus, our findings are consistent with a model in which 
PDYN neurons may promote alcohol consumption in females, but these effects may be 
mediated independent of CeA KOR neurons.  
The two sexes were also divergent at the level of PDYN neuron physiology. We 
observed that a history of ethanol drinking decreased the excitability of PDYN neurons in 
female mice, but resulted in a trend towards increased excitability in male mice.  Given that 
PDYN knockout resulted in decreased alcohol intake in both sexes, this suggests that PDYN 
knockout may have different effects on CeA physiology that result in a common phenotypic 
endpoint. As the study by Anderson et al. (2018) only examined male animals, it possible 
then that CeA PDYN neuron activation may increase alcohol drinking in male mice, but 
decrease alcohol intake in female mice.  In the present study we did not observe any effects 
of DID on spontaneous excitatory and inhibitory transmission in either sex. However, as 
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changes in PDYN/KOR signaling may occur without affecting spontaneous transmission, 
future studies should examine how a history of alcohol drinking affects KOR regulation of 
synaptic transmission in the CeA and endogenous PDYN tone. 
Another important finding was that knockout of neither PDYN nor KOR protected 
against ethanol withdrawal-induced increases in anxiety. While ethanol vapor exposure and 
ethanol liquid diet have been shown increase anxiety-like behavior in rodent models 
(Overstreet, Knapp, & Breese, 2004; Pleil, Lowery-Gionta, et al., 2015; Rose et al., 2016; 
Valdez & Harshberger, 2012), increased anxiety after DID typically has not been observed 
(Cox et al., 2013). One notable difference in the present study is that animals were run in the 
EPM 8 hrs after the binge exposure rather than 24 hrs later. Because withdrawal symptoms 
peak around 8-12 hours after ethanol (Goldstein, 1972), it is possible that these experiments 
may have captured changes in anxiety that were not present at other time points. 
Additionally, there was no significant main effect of PDYN and KOR knockout or 
interaction with ethanol treatment on anxiety-like behavior suggesting that the reductions in 
alcohol drinking were mediated without concomitant changes in anxiety levels. 
One limitation of this study is that we did not examine the outputs of CeA PDYN and 
KOR neurons. Recently it has been demonstrated that optogenetically inhibiting CeA CRF 
projections to the BNST reduces ethanol vapor-induced increases in ethanol self-
administration (Guglielmo et al., 2019). Given the high overlap of PDYN and CRF in the 
CeA (J. Kim et al., 2017), PDYN projections to the BNST may be one likely output 
mediating these effects. Additionally, as we hypothesize the balance of excitation between 
these two populations is important for regulating alcohol intake, it would be informative to 
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trace the outputs of KOR neurons. Identifying any common or divergent outputs of these two 
populations would provide further insight into what behavioral processes may be affected.  
The major advancement of the present study was to identify the effects of PDYN and 
KOR signaling in the CeA in regulating alcohol drinking. Additionally, they do so in a sex-
specific manner without affecting general taste preference or anxiety-like behavior. These 
findings contribute to our growing appreciation that the specific effects of KOR signaling in 
different brain regions may diverge from effects seen with global manipulations. Indeed, 
PDYN and KOR activation in the NAc has led to both appetitive and aversive responses 
based on anatomical sub-region that was targeted (Al-Hasani et al., 2015; Castro & Berridge, 
2014). Additionally, as KORs may be differentially expressed on different cell types within a 
brain region and shape output (Tejeda et al., 2017), it is becoming increasingly important to 
examine the effects of KOR activation in the projection-specific circuits in which they are a 
part. For example, KOR inhibition of GABAergic projections to the BNST are mediated 
through ERK 1/2 whereas KOR inhibition of glutamatergic BLA inputs are mediated by 
p38/MAP Kinase (Crowley et al., 2016; C. Li et al., 2012). These differences can then be 
exploited therapeutically as biased agonists (Bohn & Aubé, 2017; Brust et al., 2016; Ho et 
al., 2018) and could then be used to shift the balance of inputs from one brain region to 







Figure 3.1 - PDYN and KOR are expressed on different subsets of CeA neurons and is 
not altered by a history of ethanol drinking. 
(a) Timeline for experimental procedures (b) Representative image of PDYN and KOR 
mRNA expression in the CeA (c) Quantification of PDYN+ and KOR+ cell counts following 
experimental manipulations. Ethanol treatment did not affect the proportion of PDYN+, 
KOR+, and colocalized neurons Χ2(2)=1.494, p=0.474 (d) Ethanol treatment did not affect 
KOR gene expression t(9.04)=0.64, p= 0.534 or (e) PDYN gene expression t(11.899)=0.108, 
p=0.916. (c) n=12 images from N=3 ethanol or water drinking mice (d-e) punches from n=8 






Figure 3.2 - CeA KOR knockout decreases ethanol consumption in male, but not female 
mice. 
(a) Timeline for experimental procedures (b) Hypothesized actions of CeA KOR knockout 
(c) Representative images of control virus expression (left) and knockout virus (right) (d-j) 
Ethanol consumption in male animals: (d) Group averages for individual sessions over the 
course of four weeks of DID. Consumption at both the two hour and four-hour time points 
are plotted separately on day 4 (e) Cumulative averages by group for four weeks of DID. 
CeA KOR knockout significantly decreased alcohol consumption in male animals, main 
effect of condition F(1,12)=7.100, p=0.021; condition X cycle interaction F(3,36)=0.324, 
p=0.808 (f) Cumulative totals from individual mice (g) KOR knockout resulted in a 
significant reduction in the amount of alcohol consumed during IA, main effect of genotype: 
F(1,12)=13.628, p=0.003 (h) KOR knockout did not affect total fluid intake during IA, main 
effect of genotype: F(1,12)=1.652, p=0.223 (i) KOR knockout resulted in a significant 
reduction in ethanol preference: F(1,12)=6.616, p=0.024 (j) KOR knockout significantly 
reduced the cumulative amount of ethanol consumed during IA, main effect of genotype: 
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F(1,12)=13.694, p<0.001 (k-q) Ethanol consumption in female mice: (k) Group averages for 
individual sessions over the course of four weeks of DID. Consumption at both the two hour 
and four-hour time points are plotted separately on day 4 (l) Cumulative averages by group 
for four weeks of DID. CeA KOR knockout did not significantly alter alcohol consumption 
in female animals, main effect of condition  F(1,17)=0.909, p=0.353; cycle X condition 
interaction F(3,51)=0.614, p=0.609 (m) Cumulative totals from individual mice (n) KOR 
knockout did not alter the amount of alcohol consumed during IA, main effect of genotype: 
F(1,17)=0.196, p=0.663 (o) KOR knockout did not affect total fluid intake during IA, main 
effect of genotype: F(1,17)=0.232, p=0.636 (p) KOR knockout did not alter ethanol 
preference, main effect of genotype: F(1,17)=0.512, p=0.484 (q) KOR knockout did not 
affect cumulative ethanol consumption during IA, main effect of genotype: F(1,17)= 0.263, 







Figure 3.3 - CeA KOR knockout does not alter the preference of palatable or aversive 
tastants 
(a) Timeline for tastant experiments. Ethanol naïve animals underwent two bottle choice 
(2BC) for series of palatable (saccharin and sucrose) or aversive (quinine) tastants. The 
presentation of the first series (palatable or aversive) was counterbalanced across multiple 
cohorts. Following completion of the two bottle choice experiments, animals then had binge 
access to 10% sucrose during same access schedule as DID (b-d) Experiments in male 
animals: (b) CeA KOR knockout did not alter preference for quinine at the range of 
concentrations tested, main effect of genotype: F(1,14)=0.005, p=0.945 (c) KOR knockout 
did not alter for preference for saccharin or sucrose, main effect of genotype: F(1,14)=3.015, 
p=0.104 (d) KOR knockout did not affect binge consumption of sucrose at any of the two 
hour time points, main effect of genotype: F(1,12)=1.435, p=0.254 or four hour time point on 
the final day t(13.168), p=0.193 (e-g) Experiments in female animals: (e) CeA KOR 
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knockout did not alter preference for quinine at the range of concentrations tested, main 
effect of genotype: F(1,14)=2.069, p=0.172 (f) KOR knockout did not alter for preference for 
saccharin or sucrose, main effect of genotype: F(1,14)=0.175, p=0.682 (g) KOR knockout 
did not affect binge consumption of sucrose at any of the two hour time points, main effect of 
genotype: F(1,14)=0.007, p=0.979 or four hour time point on the final day t(11.655), p=0.397 









Figure 3.4 - Validation of PDYN-Flox Line 
(a) Cloning vector used to target PDYN gene (b) Experimental timeline for virus injection 
and histology (c) Injection of an adeno associated virus containing Cre recombinase results in 
a significant reduction in the number of PDYN+ cells in the CeA t(21)= 4.663, p<0.001 (d) 
The size of the ROI drawn was no different between groups t(19.953)=1.660, p=0.113 (e) 
Representative image of PDYN mRNA expression in a control mouse and (f) In a PDYN 







Figure 3.5 - CeA PDYN knockout decreases ethanol consumption in male and female 
mice 
(a) Timeline for experimental procedures (b) Hypothesized actions of CeA PDYN knockout 
(c) Representative images of control virus expression (left) and knockout virus (right) (d-j) 
Ethanol consumption in male animals: (d) Group averages for individual sessions over the 
course of four weeks of DID. Consumption at both the two hour and four-hour time points 
are plotted separately on day 4 (e) Cumulative averages by group for four weeks of DID. 
CeA PDYN knockout significantly decreased alcohol consumption in male animals, main 
effect of genotype: F(1,11)=6.899, p=0.024; genotype X cycle interaction F(3,33)=0.753, 
p=0.528 (f) Cumulative totals from individual mice (g) PDYN knockout resulted in a 
significant reduction in the amount of alcohol consumed during IA, main effect of genotype: 
F(1,11)=4.860, p=0.0497 (h) PDYN knockout did not affect total fluid intake during IA, 
main effect of genotype: F(1,11)=1.485, p=0.248 (i) PDYN knockout did not affect ethanol 
preference, main effect of genotype: F(1,11)=3.788, p=0.078 (j) PDYN knockout did not 
significantly reduce the cumulative amount of ethanol consumed during IA F(1,11)=3.943, 
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p=0.073 (k-q) Ethanol consumption in female animals: (k) Group averages for individual 
sessions over the course of four weeks of DID. Consumption at both the two hour and four 
hour time points are plotted separately on day 4 (l) Cumulative averages by group for four 
weeks of DID. CeA PDYN knockout did not significantly alter alcohol consumption in 
female animals, main effect of genotype: F(1,17)=2.707, p=0.118; genotype X cycle 
interaction F(3,51)=1.643, p=0.191 (m) Cumulative totals from individual mice (n) PDYN 
knockout significantly reduced the amount of alcohol consumed during IA, main effect of 
genotype: F(1,17)=4.490, p=0.049 (o) PDYN knockout did not affect total fluid intake during 
IA, main effect of genotype: F(1,17)=4.450, p=0.501 (p) PDYN knockout significantly 
reduced ethanol preference, main effect of genotype: F(1,17)=6.766, p=0.019 (q) PDYN 
knockout did not affect cumulative ethanol consumption during IA, main effect of genotype: 
F(1,17)=4.135, p=0.579 (d-j) n=7 control males and n=6 knockout males (k-q) n=10 control 






Figure 3.6 - CeA PDYN knockout does not alter the preference of palatable or aversive 
tastants 
(a) Timeline for tastant experiments. Ethanol naïve animals underwent two bottle choice 
(2BC) for series of palatable (saccharin and sucrose) or aversive (quinine) tastants. The 
presentation of the first series (palatable or aversive) was counterbalanced across multiple 
cohorts. Following completion of the two bottle choice experiments, animals then had binge 
access to 10% sucrose during same access schedule as DID (b-d) Experiments in male 
animals: (b) CeA PDYN knockout did not alter preference for quinine at the range of 
concentrations tested, main effect of genotype: F(1,13)=0.752, p=0.402 (c) PDYN knockout 
did not alter for preference for saccharin or sucrose, main effect of genotype: F(1,13)=0.093, 
p=0.765 (d) PDYN knockout did not affect binge consumption of sucrose at any of the two 
hour time points, main effect of genotype: F(1,11)=0.322, p=0.582 or four hour time point on 
the final day t(12.963)=0.306, p=0.764 (e-g) Experiments in female mice: (e) CeA PDYN 
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knockout did not alter preference for quinine at the range of concentrations tested, main 
effect of genotype: F(1,13)=1.119, p=0.309 (f) PDYN knockout did not alter for preference 
for saccharin or sucrose, main effect of genotype: F(1,13)=1.331, p=0.269 (g) PDYN 
knockout did not affect binge consumption of sucrose at any of the two hour time points, 
main effect of genotype: F(1,12)=1.184, p=0.298 or four hour time point on the final day 
t(13.18)=0.325, p=0.750 (b-d) n=7 control males and n=8 knockout males (e-g) n=8 control 






Figure 3.7 - KOR Knockout and PDYN Knockout Do Not Protect Against Ethanol-
Induced Increases In Anxiety-Like Behavior 
(a) Experimental timeline (b) There was a significant main effect of ethanol drinking 
F(1,29)=5.739, p=0.023 but not gene knockout F(1,29)=1.651, p=0.209 on open arm time (c) 
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There was a significant main effect of ethanol drinking F(1,29)=4.372, p=0.045 but not gene 
knockout F(1,29)=0.388, p=0.538 on open arm entries (d) There was no effect of ethanol 
drinking F(1,29)=0.522, p=0.476 or gene knockout F(1,29)=2.18, p=0.151 on total distance 
traveled in the elevated plus maze (e) There was no significant effect of ethanol drinking 
F(1,39)= 1.765, p=0.192 or gene knockout F(1,39)=0.332, p=0.568 on open arm time (f) 
There was a significant main effect of ethanol drinking F(1,39)=5.718, p=0.022 but not gene 
knockout on open arm entries (g) There was no effect of ethanol drinking F(1,39)=0.582, 
p=0.450 or gene knockout F(1,39)=0.081, p=0.777 on total distance traveled (h) There was 
no effect of ethanol drinking F(1,22)=2.092, p=0.162 or gene knockout F(1,22)=1.106, 
p=0.304 on open arm time (i) There was no effect of ethanol drinking F(1,22)=0.180, 
p=0.676 or gene knockout F(1,22)=0.037, p=0.849 on open arm entries (j) There was a 
significant main effect of ethanol treatment F(1,22)=8.523, p=0.008 but not gene knockout 
F(1,22)=0.152, p=0.701 on total distance traveled (k) There was no effect of ethanol drinking 
F(1,22)=0.591, p=0.450, or gene knockout F(1,22)=0.031, p=0.861 on open arm time (l) 
There was no effect of ethanol drinking F(1,22)=1.821, p=0.191 or gene knockout 
F(1,22)=0.925, p=0.347 on open arm entries (m) There was no effect of ethanol drinking F(1, 
22)=1.401, p=0.249 or gene knockout F(1, 22)=0.001, p=0.975 on total distance traveled 
(b-d) n=8 ethanol control males, n=7 ethanol knockout males, n=9 naïve control males, n=7  
naïve knockout males (e-g) n=9 ethanol control females, n=10 knockout females, n=7 naïve 
control females, n=10 knockout females (h-j) n=7 ethanol control males, n=6 ethanol 
knockout males, n=6 naïve control males, n=6 naïve knockout males (k-m) n=10 ethanol 





Figure 3.8 - Ethanol Drinking Does Not Alter Synaptic Transmission Onto CeA 
Dynorphin Neurons 
(a-d) Synaptic transmission in male animals (a) Representative traces of excitatory and 
inhibitory events onto CeA dynorphin neurons (b) Ethanol drinking did not alter the 
amplitude of excitatory t(11.152)=0.334, p=0.745 or inhibitory transmission t(14.704)=1.644, 
p=0.121 (c) Ethanol drinking did not alter the frequency of excitatory transmission 
t(13.390)=0.075, p=0.941 or inhibitory transmission t(11.767)=0.815, p=0.431 (d) synaptic 
drive was also unaltered after alcohol drinking t(10.982)=0.153, p=0.881(e-h) Synaptic 
transmission in female animals (e) Representative traces of excitatory and inhibitory events 
onto CeA dynorphin neurons (f) Ethanol drinking did not alter the amplitude of excitatory 
transmission t(9.164)=1.170, p=0.272 or inhibitory transmission t(12.847)=0.046, p=0.964 
(g) Ethanol drinking did not alter the frequency of excitatory transmission t(10.198)=0.966, 
p=0.356 or inhibitory transmission t(12.731)=0.950, p=0.359 (h) synaptic drive was also 
unaltered after alcohol drinking t(11.806)=1.182, p=0.260 (a-d) Water male n=10 cells, N=6 
mice; Ethanol male n=9 cells, N=4 mice (e-g) Water female n=7 cells, N=4 mice; Ethanol 





Figure 3.9 - Ethanol Drinking Alters the Excitability of Dynorphin Neurons In A Sex-
Specific Manner 
 (a) There was no effect of ethanol drinking on resting membrane potential t(12.254)=1.154, 
p=0.271 (b) Ethanol drinking did not change action potential threshold t(10.049)=0.175, 
p=0.865 (c) There was no significant difference in the amount of current injected needed to 
elicit an action potential t(9.597)=1.547, p=0.154 (d) There was a nonsignificant trend 
towards increased number of action potentials fired in the VI plot F(1,11)=0.515, p=0.488; 
F(10,110)=1.609, p=0.113 (e) There was no effect of ethanol drinking on resting membrane 
potential t(10.957)=0.044, p=0.966 (f) action potential threshold t(10.995)=0.773, p=0.456 or 
(g) rheobase t(10.458)=0.299, p=0.771 (h) ethanol drinking significantly decreased the 
number action potential fired in the VI plot  F(1,15)=4.622, p=0.048. water male: n=7 cells 
from N=4 mice; ethanol male: n=9 cells from N=5 mice; water female: n=9 cells from N=6 










Cm (sem) Rm (sem) Cm (sem) Rm (sem) 
Male 74.33 (9.00) 139.44 (24.24) 65.81 (8.24) 156.27 (16.32) 









Cm (sem) Rm (sem) Cm (sem) Rm (sem) 
Female 82.38 (6.52) 210.51 (19.44) 81.26 (6.68) 388.67 (79.45) 
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CHAPTER 4: DISCUSSION 
A central theme of this thesis is understanding commonalities between substance use 
disorder and mood disorder alterations in amygdala circuitry. In chapter 2, we find that PFC 
projections to the BLA undergo plasticity following fear extinction training, and that 
activation of this pathway is required for successful recall of the extinction memory. In 
chapter 3, we find that manipulation of PDYN and KOR signaling in the CeA regulate 
excessive alcohol intake, and that CeA PDYN neurons undergo changes in excitability in a 
sex-specific manner after a history of binge-like alcohol drinking. While these chapters 
separately assessed the effects of alcohol and fear extinction on amygdala function, in reality 
these phenomena do not occur in isolation. Rather brain circuits continuously undergo 
plasticity based on the behavioral experience of the organism. In this final chapter, we 
examine the relationship between PTSD and AUD and discuss potential interactions at the 
level of circuit physiology. 
Interactions Between PTSD and Alcohol Use 
PTSD as a Risk Factor for Alcohol Abuse 
Post-Traumatic Stress Disorder (PTSD) as well as Alcohol Use Disorder (AUD) as 
co-morbid conditions with occurring conditions (Kessler et al., 1997; Shorter, Hsieh, & 
Kosten, 2015). The predominating view is that in response to traumatic life events, 
individuals may self-medicate with alcohol to alleviate symptoms of panic and anxiety. This 
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is supported by epidemiological data showing that individuals with PTSD are 4.5 times more 
likely to develop a substance use disorder (Chilcoat & Breslau, 1998), with alcohol being the 
mostly commonly abused drug (Jacobsen, Southwick, & Kosten, 2001). Additionally, in a 
prospective study of national guard members who were deployed to Iraq, individuals with 
pre-onset PTSD symptoms were at greater risk for future alcohol abuse (Kline et al., 2014). 
Stress Enhanced Fear Learning (SEFL) has emerged as a valuable assay for 
examining aspects of PTSD in animal models (Rau, DeCola, & Fanselow, 2005) as it 
produces a heightened fear response that is resistant to extinction. In this paradigm, a pre-
conditioning stressor, in the form of repeated foot shocks, potentiates subsequent fear 
learning to a low-intensity foot shock paired with a CS. In one study that employed this 
model, rats that underwent SEFL significantly increased their alcohol drinking compared to 
animals that underwent standard fear conditioning (Meyer, Long, Fanselow, & Spigelman, 
2013). While the role of different brain regions mediating the SEFL response have been 
examined (Perusini et al., 2016), the mechanism underlying escalations in alcohol intake has 
not yet been studied. 
Effects of Alcohol on Extinction Circuitry 
By contrast, there is also the possibility that drugs of abuse may alter limbic circuitry 
to predispose individuals for developing PTSD. This idea has not been tested extensively 
from an epidemiological perspective, but in one study of individuals who underwent a motor 
vehicle accident participants with prior history of alcohol abuse were found to be at greater 
risk of later developing PTSD (Blanchard et al., 1996). Support for this idea can be found in 
the preclinical literature as well. For example, Holmes et al. (2012) found that chronic 
intermittent exposure to ethanol (CIE) does not impair the acquisition of fear extinction, but 
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impairs recall of the extinction memory. These findings are reminiscent of the PTSD state 
where individuals are unable to suppress response to CS in the absence of the aversive US. 
impairs fear extinction recall. Since alcohol exposure did not affect the degree of fear 
extinction learning, these results suggest a history of alcohol exposure impairs the recall or 
expression of the extinction memory. Moreover, Holmes et al. found that these deficits were 
mediated by reduced NMDA currents in the prefrontal cortex (PFC), a region shown to be 
hypoactive in human subjects with PTSD (Milad et al., 2009).  
It also interesting to postulate what other nodes in the fear extinction circuitry may 
also undergo maladaptive plasticity as a consequence of alcohol use. Given that basolateral 
amygdala (BLA) projections to the prelimbic (PL) region of the PFC promote fear learning 
whereas projections to the infralimbic (IL) region of the PFC promote fear extinction (Peters, 
Kalivas, & Quirk, 2009), chronic alcohol may differentially affect these brain regions to 
enhance fear learning or impair extinction recall. In support of this view, it has recently been 
shown that chronic stress enhances evoked glutamatergic transmission from the BLA in the 
PL (Lowery-Gionta et al., 2018). Additionally, optogenetic stimulation of this projection 
resulted in increased anxiety and a heightened stress response. Thus, it would be of great 
interest to examine how this output is modulated by chronic alcohol and whether alterations 








Alternative Mechanisms of Circuit Plasticity 
Role of Tonic GABA Conductances 
In chapter 3, we found sex-specific changes in dynorphin (PDYN) neuron excitability 
after a history of alcohol drinking, but no concomitant change in either spontaneous or 
evoked synaptic transmission. One possibility is that the changes in excitability may 
originate within PDYN neurons themselves as a cell-intrinsic response. Another possibility is 
that chronic alcohol may result in other types of alterations that were not examined by the 
present study. The electrophysiology experiments performed in Chapter 3 only measured the 
contribution of phasic GABAergic transmission which is thought be the result of direct 
synaptic transmission. However, there are also high affinity GABAA receptors located away 
from the synaptic cleft which are sensitive to overall ambient levels of GABA (Brown, 
Kerby, Bonnert, Whiting, & Wafford, 2002; Chadderton, Margrie, & Häusser, 2004). While 
tonic GABA conductances may contribute only a few pA of current, they can have a larger 
effect on total charge transfer than phasic transmission because of their persistent nature 
(Botta et al., 2015). Previously, there has been a role established for both α1 and δ subunit 
mediated tonic currents in the CeA (Botta et al., 2015; Herman, Contet, Justice, Vale, & 
Roberto, 2013). Additionally, tonic currents in CeA projections to the BNST are lost after 
CIE, resulting in increased excitability of these neurons (Herman, Contet, & Roberto, 2016). 
We did not examine the expression of α1 or δ containing subunits in PDYN neurons, 
however it would be of interest to examine whether either of these subunits are present and if 





Cell-Type Specific Adaptations Based on Firing Properties 
Another possibility is that changes in synaptic transmission onto PDYN neurons may 
have been masked by changes in different subpopulations of neurons. Although we 
performed recordings from a genetically defined cell type, CeA PDYN neurons still 
demonstrated a variety of firing patterns. CeA medium spiny neurons have been classified 
into three distinct categories based on their firing properties: regular spiking neurons, delayed 
spiking neurons, and low-threshold bursting neurons (Chieng, Christie, & Osborne, 2006; 
Lopez De Armentia & Sah, 2004; Schiess, Callahan, & Zheng, 1999). It has been 
demonstrated that PKCD+ neurons consist of almost exclusively the late-spiking type 
(Haubensak et al., 2010), suggesting that PKCD- neurons (presumably PDYN/SST+) consist 
of the regular spiking and low-threshold bursting types. Interestingly, low-threshold bursting 
neurons receive reduced GABAergic transmission after CIE whereas regular spiking neurons 
received increased GABAergic transmission after CIE. This is consistent with a model 
wherein chronic alcohol may simultaneously decrease the excitability of PKCD neurons and 
increase the excitability of PDYN/SST neurons.  
Alterations in Other Ethanol-Related Behaviors 
Effects on Sedative Properties of Ethanol 
Another interesting avenue of research would be to examine the effects of PDYN and 
KOR knockouts on the experience of intoxication itself. One risk factor for developing AUD 
is having a low physiological response to the sedative properties of ethanol (Schukit, 1994). 
In animal models, the sensitivity to the sedative properties of ethanol can be examined by 
measuring the duration of the Loss of Righting Reflex (LORR) in response to a high dose of 
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ethanol (4-5 g/Kg). However unlike knockout of Neuropeptide Y (NPY) (Thiele, Marsh, 
Marie, Bernstein, & Palmiter, 1998), global knockout of dynorphin did not alter the duration 
of LORR (Blednov, Walker, Martinez, & Harris, 2006). In congruence with this, cell-type 
specific ablation of the highly overlapping neurotensin (NTS) neurons in the CeA also did 
not alter LORR (Torruella-Suarez et al., 2018). The effects of KOR manipulations on LORR 
have not been examined which may be an interesting area of future research. 
Effects on Rewarding and Aversive Properties of Ethanol 
Another possibility is that the PDYN or KOR knockout may alter the rewarding or 
aversive properties of ethanol. Place preference using a classical Pavlovian conditioning 
procedure can be used to examine the effects of a manipulation on the biphasic response 
properties to ethanol (Cunningham, Okorn, & Howard, 1997). Previously, it has been shown 
that lesions of the amygdala impair both acquisition and expression of ethanol CPP (Gremel 
& Cunningham, 2008). Additionally, Delta Opioid Receptor (DOR) antagonism in the CeA 
blocked expression of previously acquired ethanol CPP and counteracted conditioned-
induced increases in glutamatergic transmission in the CeA (Bie, Zhu, & Pan, 2009). Finally, 
systemic antagonism with the non-specific opioid antagonist naloxone enhances the 
expression of ethanol CPA (Cunningham, Henderson, & Bormann, 1998), suggesting that the 
endogenous opioid system may play a role in encoding both the appetitive and aversive 






Mechanisms of Alteration of PDYN/KOR Function 
Alterations in Gene Expression 
A key assertion of our findings in chapter 3 is that chronic alcohol results in an 
upregulation of PDYN/KOR function which mediates increases in alcohol intake. This is 
supported by findings from Kissler et al. (2014) showing that chronic intermittent ethanol 
vapor increases dynorphin immunoreactivity in the CeA and that KOR antagonism decreases 
ethanol self-administration in dependent animals. This raises the question then of what is the 
molecular mechanism of enhanced PDYN/KOR function. One potential possibility may be 
through alterations in the level of the transcription factor CREB, which has been shown to 
regulate PDYN levels (Cole, Konradi, Douglass, & Hyman, 1995). Chronic cocaine increases 
both CREB and PDYN levels in the NAc (Carlezon et al., 1998), and overexpression of 
CREB can disrupt the rewarding properties of the drug via PDYN. Unlike the NAc though, 
long-term alcohol use results in a downregulation of CREB in the CeA (Pandey, Roy, & 
Zhang, 2003) presumably resulting in lower dynorphin levels. However, PDYN is regulated 
by other transcription factors such as AP-1 and ΔFosB (McClung & Nestler, 2003; Rouault, 
Nielsen, Ho, Kreek, & Yuferov, 2011) so it would be interesting to examine how these 
factors may contribute to changes in PDYN expression after a history of alcohol drinking. 
Alterations in Receptor Function 
There is also the possibility that PDYN/KOR function may undergo changes 
independent of gene expression. Indeed, many G-Protein Coupled Receptors are not 
transcriptionally regulated (Kroeze & Roth, 1998). For example, chronic treatment with the 
5-HT2A agonist mianserin results in decreased receptor binding even though mRNA levels 
are unchanged (Roth & Ciaranello, 1991). This may explain why we found behavioral effects 
118 
 
of PDYN and KOR knockout in the absence of any changes in gene expression after a history 
of alcohol drinking. The present study also did not find any effects of alcohol drinking on 
KOR inhibition of IPSCs in the CeA, although our sample size was too small to make 
definitive conclusions. However, it should be noted that in the BNST we have found that CIE 
enhances KOR inhibition of GABA (Kash Lab unpublished data), and that these alterations 
were observed even though there was reduced KOR mRNA expression.  
Additional evidence for expression-independent changes in PDYN/KOR function can 
be found in the NAc. The Jones Lab has demonstrated that chronic alcohol increases KOR 
inhibition of dopamine in the NAc of rats that underwent CIE (Rose et al., 2016) and in 
macaques that self-administered ethanol (Siciliano et al., 2015). Additionally, they find that 
an endogenous dynorphin tone develops after CIE (Karkhanis, Huggins, Rose, & Jones, 
2016), even though CIE actually lowers dynorphin protein levels in the NAc (Karkhanis, 
Rose, Weiner, & Jones, 2016). Taken together, these findings show that the KOR system 
undergoes functional changes in response to chronic alcohol across several mammalian 
species.  Future studies will thus be needed to examine the consequence of enhanced KOR 
function on downstream signal cascades. 
Dynorphin Effects Mediated Independent of KOR 
A central tenant of these findings is that reductions in alcohol drinking due to PDYN 
knockout are mediated through alterations on downstream KOR signaling. Given that (1) 
PDYN acts on KOR with the highest affinity of any endogenous opioid receptor (Chavkin, 
James, & Goldstein, 1982), (2) that PDYN and KOR form spatially adjacent populations in 
the CeA, and (3) that KOR knockout also produces a largely similar effects on alcohol 
drinking as PDYN knockout, this appears to be the most parsimonious explanation. 
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However, it is also possible that PDYN knockout and KOR knockout may act through 
different mechanisms to result in the same phenotypic endpoint. The preprodynorphin gene is 
a precursor protein which can be cleaved into Dyn-A, Dyn-B, β-neoendorphin, and leu-
enkephalin (Weber, Evans, & Barchas, 1983), with β-neoendorphin and leu-enkephalin 
having greater affinity for MOR and DOR respectively. Additionally, MOR and DOR both 
inhibit GABAergic transmission in the CeA and are differentially affected by acute ethanol 
(M.-H. Kang-Park et al., 2009; M.-H. Kang-Park, Kieffer, Roberts, Siggins, & Moore, 2007). 
Thus, this raises the possibility that the effects of PDYN knockout may have broader 
reaching effects than those mediated solely through KOR. 
Effects mediated by gene products other than Dyn-A may also explain some 
incongruities in the data. While both PDYN and KOR knockout decreased alcohol 
consumption in males, only PDYN knockout decreased alcohol intake in females. This raises 
the possibility whether Dyn-A may predominate in male animals whereas β-neoendorphin 
and leu-enkephalin may predominate in female animals. Indeed differences Dyn-A and leu-
enkephalin release have been shown even within different anatomical subregions in the NAc 
of the same animal (Al-Hasani et al., 2018), making the possibility that there are different 
concentrations of these different gene products between sexes seem quite plausible. Given 
the NIH mandate to examine sex as a biological variable (NOT-OD-15-102), future studies 
are needed to examine basal differences in the endogenous opioid system in the CeA between 






Role of Neuropeptide Markers Versus Neuropeptides Themselves 
A unique focus of the present study was on examining the effects of peptide signaling 
itself rather than using them solely as a genetic marker. This then raises the larger question of 
whether manipulation of a neuropeptide may have convergent or divergent effects of 
activating or inhibiting the cell population of which it is a part. For example, here we find 
similar results on alcohol drinking from both PDYN knockout (chapter 3) and PDYN neuron 
chemogenetic inhibition (Anderson et al., 2018). Similar to this, Zelikowsky et al. (2018) 
found convergent effects of CeA Tac2 siRNA knockdown and Tac2 neuron DREADD 
inhibition on cued fear recall. These findings support a model in which neuropeptides play a 
similar role to activation of the population as a whole. 
However, this does not preclude a scenario in which a neuropeptide may have 
opposing behavioral effects from other co-released neurotransmitters and peptides. As noted 
previously, CRF and SST exhibit a high degree of overlap in the CeA (J. Kim, Zhang, 
Muralidhar, LeBlanc, & Tonegawa, 2017; Pomrenze et al., 2015). Yet Li et al. (2013) found 
that activation of SST neurons promote a conditioned freezing in response whereas Fadok et 
al. (2017) found that activation of CRF neurons promote active avoidance. It will be 
important then to examine the role of SST and CRF peptides themselves, and examine 
whether they may be involved in mediating this divergent behavioral response. We have also 
observed scenarios in which manipulation of a peptide does not match the effects of 
manipulating the cell population as a whole. Consistent with what has been shown with CeA 
CRF neurons (Pomrenze et al., 2019), we have found that chemogenetic activation of CeA 
PDYN neurons increases anxiety-like behavior (Kash Lab Unpublished Data). However, in 
chapter 3 we do not find any changes of PDYN knockout on anxiety-like behavior, 
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suggesting that the dynorphin peptide itself may not be involved in mediating the anxiety 
response. 
Further complicating matters is the fact that co-released neuropeptides may have 
opposing effects on the excitability of downstream neurons. For example, we postulate that 
activation of CeA PDYN neurons would lead to increased release of GABA, dynorphin, 
CRF, as well as potentially other peptide transmitters. GABA would lead to the 
hyperpolarization of the post-synaptic neuron (Pomrenze et al., 2015) whereas dynorphin 
may result in disinhibition by inhibiting presynaptic GABA release (Gilpin, Roberto, Koob, 
& Schweitzer, 2014; M. Kang-Park, Kieffer, Roberts, Siggins, & Moore, 2013). Likewise, 
CRF could result in either excitation, by potentiating release of glutamate (Silberman & 
Winder, 2013), or inhibition, by increasing the release of GABA (Nie et al., 2009). In turn, 
activating even one genetically defined cell type likely has complex effects on the balance of 
synaptic transmission within a given brain region (for example see Figure 4.1). 
It is interesting then to speculate as to what the normal function of peptide co-release 
may be, and how it may be altered in maladaptive states. For example, Sanford et al. (2017) 
demonstrated that CRF release in the CeA is required for fear learning at low, but not high 
US intensities. Given that CRF increases glutamatergic transmission in the CeA (Silberman 
& Winder, 2013), one possibility is that CRF may facilitate learning at low shock intensities 
by increasing excitatory drive onto PKCD neurons which integrate the US signal (S. Han, 
Soleiman, Soden, Zweifel, & Palmiter, 2015; Yu et al., 2017). As chronic alcohol increases 
CRF levels in the CeA (Roberto et al., 2010), this may be one mechanism by which alcohol 
use confers risk for PTSD.  
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There is then also then the question of how different neuropeptides may interact with 
one another. Kang-Park et al. (2015) have demonstrated that CRF potentiates the release of 
dynorphin in the CeA. Additionally, Bruchas et al. (2009) demonstrated that dynorphin is a 
mediator of CRF increases in anxiety in the BLA. It is also possible that dynorphin may 
engage CRF circuitry in order to mediate a behavioral response. As chronic alcohol increases 
both PDYN and CRF levels in the CeA (Kissler et al., 2014; Roberto et al., 2010), this raises 
the question of whether the mechanism of upregulation is due to a positive feedback loop 
between these two neuropeptides. 
Role of Genetically-Defined Versus Anatomically-Defined Outputs 
An overarching theme of this dissertation has been to find neuronal cell populations 
within a brain region that play opposing roles in governing behavior. A large ongoing 
question in circuit neuroscience is which type of specificity is most important: genetic, 
output, or activity defined? In this thesis, we take the position that potentially all may be of 
interest. In chapter 2, we find that fear extinction results in subregion and output-specific 
changes in the excitability of PFC neurons. Additional examples of this can be seen in the 
literature wherein manipulation of different CeA outputs, irrespective of their cell type, 
separately control predator seeking versus capture behavior (W. Han et al., 2017). By 
contrast in chapter 3, we find that manipulation of two genetically defined cell types in the 
CeA, without regard to their output identity, are involved in regulating alcohol drinking. This 
is analogous to what has been demonstrated of the separable roles of SST and PKCD neurons 
in mediating the conditioned fear response (Haubensak et al., 2010; Li et al., 2013). Given 
that there are different effects of SST somatic versus terminal activation (J. Kim et al., 2017; 
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Pomrenze et al., 2018), this provides support for a scenario in which both genetic and output 
identity can be of importance.  
There is also then the possibility of whether certain types of neurons may be 
functionally pre-selected to participate in a behavior. One theory of memory allocation is that 
an event may encoded by only on a sparse population of neurons, termed an “engram”, 
whereupon reactivation of this population alone is sufficient to recapitulate the memory 
experience. In support of this idea, it has been shown in the lateral amygdala (LA), that 
neurons expressing phosphorylated CREB are preferentially incorporated into a fear engram 
(J.-H. Han et al., 2007). This engram is largely static in size (J.-H. Han et al., 2009; Zhou et 
al., 2009) and increasing the relative excitability of a subset of neurons can bias their 
incorporation into the engram (Yiu et al., 2014).  
In contrast to the LA, it may be the case that the CeA SST and PKCD neurons are 
hard-wired to be “fear on” and “fear off” cell types. Support for this idea comes from the 
finding that these cell types innately show divergent firing properties in response to CS 
presentations (Ciocchi et al., 2010), and that these cell types have different patterns of input 
and output connectivity (J. Ye & Veinante, 2019). Additionally, as these cell types show 
differential D1 versus D2 receptor expression (J. Kim et al., 2017), this provides support for 
a model in which these cell types play a pre-determined function similar to the direct and 
indirect pathways in the striatum. Thus, an interesting test of this hypothesis would be to see 
whether the “fear on” neurons could be functionally manipulated to become “fear off” 
neurons and vice versa (Figure 4.2).  
Given the number of new tools being developed to manipulate neuronal cell types 
based on their activity (Guenthner, Miyamichi, Yang, Heller, & Luo, 2013; Reijmers, 
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Perkins, Matsuo, & Mayford, 2007; Sakurai et al., 2016) this will be an area of interesting 
future research. For example, it has shown been shown that in the prefrontal cortex, distinct 
sets of outputs are recruited in response to stimuli of opposing valence (L. Ye et al., 2016). 
However as many of these techniques rely on immediate early gene markers, the temporal 
precision of these manipulations can only be measured on the order of hours or days 
(DeNardo et al., 2019; Liu et al., 2012). Excitingly, new technologies are being developed 
which would allow for activity-dependent manipulations to instead be dependent on calcium 
influx which would greatly improve their temporal resolution (Wang et al., 2017). While the 
precision of these techniques is still on the order of minutes, improvements in signal 
transduction would hopefully enable a resolution on the order of seconds, allowing for the 
tagging of neurons to stimuli as brief as CS and US presentations. 
Using Sequencing Technologies to Refine Neural Circuits 
Another major advancement has been the development of sequencing technologies to 
examine the gene expression of individual neurons (Macosko et al., 2015). Single-cell 
droplet sequencing (Drop Seq) holds great potential to reveal expression changes after a 
behavioral manipulation or to characterize the genetic diversity of a brain region. For 
example, comparing in situ hybridization of different CeA populations has been very helpful 
for classifying which types of markers may be distinct or overlapping (J. Kim et al., 2017). 
However, single cell sequencing permits the identification of many more markers within the 
same cell, allowing more complex analyses such as hierarchal clustering to be performed. 
Additionally, the ability to recover individual neurons from electrophysiology recordings 
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(Patch Seq), allows for functional properties, such as the firing patterns of neurons, to be 
mapped onto genetic identity (Cadwell et al., 2016).   
Single cell sequencing also holds potential to advance our understanding of 
neuroanatomy as well. In chapter 2, we make the conclusion that on the basis of little overlap 
between BLA-projecting and NAc-projecting neurons in the PFC that these must be distinct 
outputs. However, anatomical conclusions based on retrograde tracers are inherently limited 
by the fact that infusion into the downstream target will not reach all afferent synapses. Thus, 
as noted previously, the percentage of overlapping BLA-projecting and NAc-projecting 
neurons is likely an underestimate. New technologies such as Map-seq (Kebschull et al., 
2016) provide a solution to this problem as it relies on anterograde tracing. Through virally-
delivered genetically unique barcodes, this allows for the entire brain wide outputs of a single 
neuron to be identified. Using this approach would provide a more quantitative measure of 
the degree of collateralization between outputs, as well as identify any other unique aspects 
of the projection patterns of these cell types. 
One inherent limit of these sequencing technologies though is that they require either 
tissue dissociation or homogenization which results in the loss of anatomical context. For 
example, the overlap of CALCRL and PKCD shows clear differences along the 
anterior/posterior axis of the CeA (S. Han, Soleiman, Soden, Zweifel, & Palmiter, 2015). 
Additionally, BLA outputs appear preferentially in layer II/III in the PFC whereas NAc 
outputs predominate in layer V (chapter 2). This information would have been lost in tissue 
punches, and presents a case for using sequencing and classical anatomical techniques to be 
used in tandem. For example, sequencing can be used as a first pass to gain broad insights 
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into the diversity of population which can then be followed up with traditional tracing and in 
situ hybridization techniques to provide greater anatomical detail. 
Leveraging Circuit Insights to Improve Psychiatric Treatment 
Ultimately, these differences in anatomical distribution of PFC outputs to the BLA 
and NAc may prove to be of therapeutic relevance. For example, transcranial magnetic 
stimulation (TMS) of the prefrontal cortex has proved highly effective at maintaining 
abstinence in individuals with a cocaine addiction (Terraneo et al., 2016). This trial was 
largely based on the finding that stimulation of prefrontal cortex outputs to the NAc facilitate 
the extinction of cocaine seeking (Augur, Wyckoff, Aston-Jones, Kalivas, & Peters, 2016; 
Chen et al., 2013). Given that the prefrontal cortex also facilitates extinction in the aversive 
domain (Do-Monte, Manzano-Nieves, Quiñones-Laracuente, Ramos-Medina, & Quirk, 2015; 
H.-S. Kim, Cho, Augustine, & Han, 2016), a subsequent trial demonstrated that TMS could 
enhance extinction of conditioned fear in human subjects (Raij et al., 2018). Together, these 
findings show that TMS of the PFC may be a promising therapeutic target for both substance 
use disorders and PTSD. 
Current research is examining many different frequencies of magnetic stimulation and 
examining the effects on different cell types. It has now been found that certain types of 
stimulation may preferentially activate layer II/III versus layer V neurons (Diana et al., 
2017). Given that we find a dissociation in the anatomical layers of BLA and NAc outputs in 
the PFC, our findings suggest that different patterns of magnetic stimulation may prove more 
effective for treating substance use disorders versus PTSD. In turn, this multi-faceted 
approach which integrates analysis at the molecular, electrophysiological, and anatomical 
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levels provides a deeper insight into the function into the brain’s emotional networks. By 
modeling common circuit alterations across species, this translational approach holds great 
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